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Bengtson, Melanie, M.S., August 2002 Chemistry
NONACTIN BIOSYNTHESIS: STUDIES TOWARD THE SYNTHESIS OF STABLE 
ISOTOPE LABELED POTENTIAL PRECURSORS
Director: Nigel D. Priestley
Nonactin is a polyether antibiotic macrotetrolide produced by Streptomyces griseus that 
is a potent inhibitor of the P 170-glycoprotein efflux pump responsible for drug resistance 
in cancer cell lines. Nonactin is an atypical polyketide that consists of four monomer 
units of nonactate. Previous studies have confirmed that the primary metabolic 
precursors of nonactate are acetate, propionate and succinate. The late intermediate in 
the nonactate biosynthesis has been confirmed by feeding studies. The biosynthesis 
pathway from the primary metabolites to the late intermediate have so far not been 
confirmed.
A synthesis for an unconfirmed intermediate, a [2,3-’^C]-6,8-dihydroxy-2- 
methylnonanethioic ester, has been proposed with unlabeled material and nearly 
completed. The synthesis is based on the Mg*^-pyridine dependent coupling of p- 
ketoesters and acyl halides and the introduction of stereochemistry by stereoselective 
reduction using chiral ruthenium complexes to afford anf/-1,3-diols. The most promising 
synthesis was completed through (3R,5R)-3,5-diacetoxyhexan-1-ol, which at this point 
requires conversion into (4R,6R)-4,6-diacetoxyheptan-1-al. In order to couple 
propionate stereospecifically to (4R,6R)-4,6-diacetoxyheptan-1-al, the chiral auxiliary 
(4S)-4-(phenylmethyl)-propanoyl-1,3-oxazolidinone was prepared. An efficient 
synthesis for [2-’^C]-propionic acid was developed with unlabeled material.
11
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CHAPTER 1
INTRODUCTION
1.1 Natural Products and Antibiotics
Natural products have long been a source of compounds of medicinal value/ A 
wide range of biologically active secondary metabolites has been identified by screening 
for antibacterial and antifungal properties, but with the advent of modern screening 
methods, many natural products with antiviral, antitumor, antimetabolic, and 
immunological activities have been identified. Among the natural products of clinical or 
agricultural importance, most are produced by Actinomycetes, in particular by the genus 
Streptomyces}
With modern assays, natural products can not only be screened for 
antiproliferative properties but also tested for inhibition of enzymes, gene expression, 
and signal transduction. Traditionally, antibacterial compounds were the most studied 
category within the natural products. The emergence of new infectious diseases, many 
of which can not be treated effectively, has led to renewed research for new active 
compounds. Aside from emerging diseases, many bacterial strains are exhibiting 
antibiotic resistance, which has become a major public health issue, as the number of 
infective diseases that can be treated effectively decreases.^ Even for antibiotics such 
as vancomycin, that have been used only as a last defense when all else fails, the 
number of resistant strains has drastically increased."^ The ultimate goal of antibiotic 
research is to discover and characterize fundamentally different and new compounds
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
and to study in detail all the applications of the natural products that are commercially 
available using new technology and assays.®
Natural products are intrinsically complex and thus difficult to synthesize. For 
example the first total synthesis of penicillin (1) by Sheehan et al. took nearly ten years 
to develop.®
H H
Me
penicillin V (1)
Synthesis can, however, be used to study the natural biosynthesis pathways and 
the mechanisms by which the organism assembles the final natural product. Research 
of the genetics involved in the process complements the chemistry.^ Knowledge of the 
genes involved in the biosynthesis permits the manipulation of the biosynthesis 
pathways.® The microbial organism can, for example, be used for the production of the 
final product, or a late intermediate can be isolated by modifying the genes. The 
intermediate can be chemically converted into a range of analogues. Libraries of 
potential active compounds can be produced in this manner, which is much more 
effective than synthesizing them individually. Once the chemistry is known and the 
genetics have been elucidated, the pathway can be manipulated for development and 
finally the production of new drugs.
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1.2. Polyketides
Polyketides constitute a broad class of natural products. They are synthesized 
by large protein complexes, referred to as polyketide synthase (PKS) complexes. 
Polyketide biosynthesis is related to fatty acid biosynthesis, so it is important to 
understand fatty acid biosynthesis.® All reactions in fatty acid biosynthesis are catalyzed 
by a complex of enzymes called the fatty acid synthase (FAS). The FAS complex from 
Escherichia coli for example consists of seven proteins.^® The structure of the FAS 
complex differs from organism to organism, but the reactions it catalyzes are universal. 
Fatty acid biosynthesis is a four-step elongation process (Figure 1). Initially, an acyl 
carrier protein ketosynthase (ACP-KS) of the enzyme complex accepts an acetyl group 
with its free thiol, a process catalyzed by acetyl-CoA-ACP transacetylase, and the acetyl 
group is transferred to a neighboring ketosynthase (KS). The acyl carrier protein 
ketosynthase (ACP-KS) now has a free cysteine residue again which is charged with a 
malonyl group, catalyzed by malonyl-CoA-ACP transferase. The enzyme complex is 
now charged for the first step, a decarboxyiative Claisen condensation. A (3-ketoacyl- 
ACP synthase (KS) catalyzes the reaction, which generates a molecule of carbon 
dioxide. In the second step, the p-keto carbonyl of the acetoacetyl group is reduced by 
p-ketoacyl-ACP reductase (KR) with the reduced form of nicotinamide adenine 
dinucleotide (NADPH) serving as the electron donor, resulting in a p-hydroxyacyl-ACP 
complex. In the following step, p-hydroxyacyl-ACP dehydratase (DH) catalyzes a 
dehydration reaction to give the corresponding frans-A^-acyl-ACP complex. The double 
bond is reduced in the final step by an enoyl-ACP reductase (ER) to yield the acyl-ACP 
complex. This is an NADPH-dependent step as well. Finally, the chain is transferred
back to the KS by an acyl transferase (AT) to free up the ACP for a new
3
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molecule of malonate. This process is repeated in an iterative fashion to elongate the 
chain to the desired length.
Fatty acid synthase complexes are divided into two main categories based on 
structural differences. Type I FASs are usually found in fungi and animals. They consist 
of a large modular protein complex. Each individual protein has catalytic domains for 
multiple functions, so each protein can carry out different reactions. Type II FASs are 
usually found in plants and bacteria. They consist of multiple proteins that are encoded 
by individual genes. The individual enzymes each catalyze a unique reaction. Since the 
reactions that are carried out are the same for either type, the catalytic domains of type I 
FASs are in function analogous to the individual enzymes of a type II FAS.
Like FAS complexes, systems for the synthesis of polyketides fall into two main 
structural categories, type I or type II. Type I PKS complexes synthesize the final natural 
product in a processive fashion. Modifications are carried out after each elongation step 
before the next extender unit is added. Type II PKS complexes on the other hand 
assemble the entire backbone of the molecule before modifying it. Although type I and 
type II PKS utilize the same reactions, they result in distinctly different compounds.
1.2.1 Type I Polyketides
Two major classes of type I polyketides have been studied extensively, 
macrolides (Figure 2) and polyethers (Figure 3). The term macrolide was introduced by 
Woodward to define a number of natural antibiotics that possessed a lactone 
macrocyle. The first macrolide antibiotic reported in the literature was pikromycin (2).^^ 
Methymycin (4) was the first macrolide whose structure was de te rm in ed .T he  most 
extensively studied type I polyketide is erythromycin (6) . "  Erythromycin is a 14-
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
membered macrolactone originally isolated from Saccharopolyspora erythraea.^^ The 
erythromycin PKS consists of three large proteins that in turn each have two modules. 
The putative product of the PKS is 6-deoxyerythronolide B (10, 6-DEB), which illustrates 
the ‘processive’ assembly (Figure 4). The final antibiotic is obtained after post-PKS 
modifications (Figure 5). The modules contain the sites for catalytic activity of 
modifications, such as reductions or eliminations. After addition of a malonyl extender 
unit, the chain is modified before addition of the following extender unit. This means that 
each catalytic domain has a specific activity that is only utilized once per molecule 
synthesized.
OH
R=OH Pikromycin (2) 
R=H Narbomycin (3)
R2
M02N
OH
Ri=OH, R2=H Methymycin (4) 
Ri=H, R2=0H Neomethymycin (5)
OH
HO- NMeOH
OMe
OH
Erythromycin A (6)
Figure 2; Type I Polyketides -  Macrolides
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HQ
MeQ, HO '— OH
Monensin A (7)
MeQ
HO OH
Nigertcin (8)
Tetronasin (9)
Figure 3: Type 1 Polyketides -  Polyethers
Polyethers are the second major class of type I polyketides. Monensin A (7), an 
antibiotic used in veterinary medicine, is a polyether ionophore isolated from 
Streptomyces cinnamonensis.^^ The biosynthesis of polyethers has not been studied as 
extensively as that of macrolides. In 1979, Kishi et al. disclosed the first total synthesis 
for monensin.^^ Soon after, Still et al. proposed a different ro u te .In itia lly , monensin 
was proposed to be biologically assembled from an all-(E) triene intermediate, following 
the Cane-Celmer-Westley hypothesis.^® The triene was synthesized but in a feeding 
study, it failed to incorporate.^^ This lead to the development of an alternative 
hypothesis for the biosynthesis, the Townsend-Basak-McDonald proposal. The 
suggestion was that monensin is obtained from an ali-(Z) triene intermediate. The
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module-1 module-2 module-3 module-4 module-5 module-6
AT.ACP.KS.AT.KR.ACP.KS.AT.KR.ACP KSAT.ACP.KS.AT.DH.ER.KR.ACP KS.AT.KR.ACP.KS.AT.KR.ACP.TE
HO H O "HO'" HO"
HO"HO
HO' H O "
HO
HO"'HO'
HO'OH
'OH
6-deoxyerythronolide B (10)
Figure 4: Synthesis of 6-DEB
intermediate is proposed to undergo a series of metal-mediated syn-oxidative cyclization 
reactions to give the sequence of cyclic ethers.^^ The difference between the Cane- 
Celmer-Westley hypothesis and the Townsend-Basak-McDonald proposal is the 
stereochemistry of the product (Figure 6). There is biomimetic experimental evidence 
that supports the Townsend-Basak-McDonald proposal.^^
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Figure 5: Post-PKS Modifications of 6-DEB
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
, -  r w " '  —
OH Rb o h  O Rb ^  Rb
" •  0 - < " *  —OM B . a . ^ .  R, "  B .
Figure 6: Stereochemical outcome in Cane-Celmer-Westley hypothesis (top) vs. 
Townsend-Basak-McDonatd-Proposal (bottom)
1.2.2 Type II Polyketides
Type II polyketide synthase complexes resemble type II FAS complexes. The 
synthesis is performed by individual proteins, rather than domains of a large complex. 
Each protein, with the exception of ketoreductase (KR) enzymes, has a specific function 
that can be utilized more than once in the synthesis of a single molecule. The 
modifications, such as reductions and eliminations, are likely carried out after the 
backbone has been assembled. The chain elongation is exclusively carried out with 
malonyl-CoA as an extender unit. The intermediates have been proposed to be poly-p- 
ketones. The diversity in type II polyketides stems from the variation in chain length, the 
number of possibilities in folding and cyclization patterns, as well as the modifications 
after the intermediate is assembled. The typical products of type II PKS are polycyclic, 
aromatic compounds, such as daunorubicin (17), actinorhodin (19) and oxytetracycline 
(20) (Figure 7).
10
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Figure 7: Type II Polyketides
The best studied type II polyketide biosynthesis is the actinorhodin system. 
Actinorhodin (19) is an antibiotic isolated from Streptomyces coelicolor A3(2).^^ The 
actinorhodin gene cluster was the first PKS gene cluster to be characterized, so it has 
served as a model system since then. The biosynthesis cluster contains a minimal PKS, 
a ketoreductase (KR), a cyclase (CYC) and an aromatase (ARO). The minimal PKS is a 
three-protein complex, with a ketoacyl synthase/acyl transferase (KS/AT), later renamed 
as KSa, a chain length factor (CLF), later renamed as KSp, and an acyl carrier protein 
(ACP) (Figure 8).
n
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acU
KR KS CLF ACP " v '
_̂_________________  ̂ CYC/ARO
minPKS
Figure 8; Actinorhodin biosynthesis genes
The biosynthesis of actinorhodin is typical for a type II polyketide (Figure 9). The 
nonactin biosynthesis cluster on the other hand encodes an atypical PKS.^® The genes 
are homologues of type II PKS genes, but they differ noticeably from other type II PKS 
genes and they encode the synthesis of a non-aromatic, non-polycyclic compound, 
nonactin.
12
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1.3. Nonactin
Nonactin (27) is the parent compound of a series of homologous macrocyclic 
ionophore macrotetrolide antibiotics (Figure 10). Macrotetrolides were initially isolated 
by Prelog et al. from Streptomyces griseus ETH A7796, and subsequently from S. 
longisori and S. chrysomallus.^^ The structures were elucidated by spectroscopy and 
degradation.^® The crystal structure confirmed both structure and stereochemistry later 
on.^ The macrotetrolides are 32-membered macrocycles assembled from four 
monomer units (Figure 11). Nonactin consists of alternating (+)-nonactate (32) and (-)- 
nonactate units, so each nonactin molecule contains two (+)-nonactate and two (-)- 
nonactate molecules. The resulting macrotetrolide has S4 symmetry; therefore it is 
achiral. The nonactate units can be replaced by homononactate (33) or 
bishomononactate (34). The replacement of a nonactate unit with a homononactate unit 
results in monactin (28). Further substitution can lead to even higher homologues, the 
other naturally occurring macrotetrolides.
Ri R2 Rs R4
Nonactin (27) Me Me Me Me Me. f  \  !
Monactin (28) Me Me Et Me
Dinactin (29) Et Me Et Me
Trinactin (30) Et Et Et Me '— ' c
Tetranactin (31) Et Et Et Et
Me H
Me
Figure 10: Naturally occuring macrotetrolides
14
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R = Me (+)-nonactic acid (32) .
OH O
R = Et (+)-homononactlc acid (33)
R = 'Pr (+)-bishomononactic acid (34)
Figure 11 : Naturally occurring monomer homologues
Macrotetrolides are ionophores which can bind mono- and divalent ions. As 
such, nonactin and its homologues can transport ions across membranes. The 
structures of nonactin-ion complexes have been studied and it was found that the 
carbonyl oxygen atoms and oxygen atoms in the tetrahydrofuran rings coordinate to the 
ion while the molecule is wrapped around the ion.^° The ability for ion transport is the 
basis for its antimicrobial activity and cytotoxicity.^’
The macrotetrolides exhibit a range of activity. Nonactin is an antibiotic effective 
against Gram positive bacteria, fungi and mycobacteria.^® All homologues are active in 
vitro against tumor cell llnes.“  They also have shown anti-tumor activity in vivo in 
mice.^^ Nonactin is an efficient inhibitor of the PI 70 glycoprotein-mediated efflux of 4’- 
O-tetrahydropyranyladriamycin in multi-drug resistant erythroleukemia K562 cells.®  ̂
Nonactin shows cytotoxic effects in mammalian cells, which unfortunately precludes its 
use in clinical trials. Nonactin is a useful lead compound, and when its mechanism for 
antimicrobial activity is fully understood, the information can be used for the 
development of new compounds.
15
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Figure 12; Hypothesis for nonactin biosynthesis
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1.4. Nonactin Biosynthesis
According to early studies with radioisotope labeled compounds, nonactin is 
synthesized from acetate, propionate and succinate.^^ The monomer nonactate has 
been shown to be present in the culture. Since the initial study, nonactin biosynthesis 
has been studied by extensive feeding studies of compounds labeled with radioisotopes 
and stable isotopes.^"^’ Robinson et al.^* have postulated a biosynthesis pathway for 
nonactin based on polyketide biosynthesis, which has since been expanded by Priestley 
et al.,'*  ̂and now branches out into two enantiocomplementary pathways to yield an 
enantiomeric pair of acyclic diols (45 and 46) (Figure 12). Each enantiomer is cyclized 
by enzymes to result in (-)-nonactate and (+)-nonactate, respectively. The monomeric 
units are linked stereospecifically by enzymes to form the macrotetrolides.
The earliest sequencing work was done by Plater and R ob inson .They  isolated 
a 3.3 kbp DNA fragment from S. griseus that conferred tetranactin resistance (nonR) on 
S. lividans. The nonR gene encodes a deduced protein with an active site motif found in 
serine proteases and esterases. This early work has been continued and so far 
approximately 40 kbp have been sequenced.**^® The cluster appears to encompass a 
total of 39 kbp comprising 30 open reading frames (ORF). Out of these ORFs, ten 
appear to be part of the nonactate PKS (Figure 13), These genes encode ketoacyl 
synthase units (o/f7, nonN, nonQ, nonK and nonj), ketoacyl reductase units {nonO, 
nonP, nonM  and nonE) and a 3-ketoacid:succinyl-CoA CoA-transferase {orfS). The 
genes nonS and nonS'encode a pair of nonactate synthases, one gene potentially for 
each enantiomer. The enzyme nonR is a serine esterase, as mentioned above.
Another resistance mechanism is encoded on genes orf5/6. The deduced protein of 
orf5/6 has homology to an ABC transporter. The deduced protein NonD shows a strong
17
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homology with cocaine esterase. By homology, nonL encodes a putative ligase. The 
gene nonG has been postulated to encode a transcriptional repressor. The function of 
nonB, nonC and nonF has not been deciphered yet.
nonS' KASII KASHI KASII KR esterase nonS transcriptional
ABC TRA KR KASII
Iabc Ikasiii I kr 1 KR
figase repressor
'resistance
1 2 3  4 5 6 7  8 N Q O P K J M E D  L S R B C F G H  26 2728 29 30
4# - »)»» # #
Priestley et al.
Shen et al. Shen et al.
Figure 13: Current map of the nonactate biosynthesis cluster
The synthesis of one enantiomer of nonactate requires three condensation and 
three reduction reactions. If each enzyme was only used once In the synthesis, and 
each enantiocomplementary pathway requires Its own protein, the synthesis would 
require six synthases and six reductases. If each enzyme could catalyze the synthesis 
of either enantiomer, the cluster should have three synthases and three reductases. 
The cluster has five synthase and four reductase genes, so some of the enzymes are 
used in both pathways and some are only used In one of the enantiocomplementary 
pathways. The challenge lies in determining how the genes are shared in the two 
pathways and in understanding how stereochemical control In the synthesis Is attained.
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1.5. Current Chemical Work
There are two generally accepted methods for studying biosynthesis pathways. 
Advances in biotechnological tools opened up the possibility of studying natural product 
biosynthesis by isolation and characterization of biosynthesis genes and the proteins 
they encode. Genetic modification of the original organism, followed by studies of how 
the mutation affects the organism’s ability to make the natural product under 
investigation, have allowed the assignment of conversions in the biosynthesis to specific 
enzymes.
The classic technique for elucidating biosynthesis pathways is the feeding of 
isotopically labeled compounds into fermentative cultures. The natural products are 
subsequently isolated from the culture and analyzed. Both radioactive and stable 
isotopes have been used, but radioactive isotopes require that the substrate is 
chemically degraded, so the position of the radioactive label may be determined. Stable 
isotopes are most widely used since advances in nuclear magnetic resonance (NMR) 
spectroscopy make it possible to assign the position of the label from the spectrum of an 
entire molecule and determine the level of isotope incorporation. The most commonly 
encountered stable isotopes are and which is used in mass
spectroscopy (MS) studies. Single labeled compounds only provide information 
about the final location of an individual atom, much like radioactive isotope studies.
They do not provide information about what bonds are broken in the synthesis or the fate 
of the hydrogen atoms. This has led to the use of dual labels.
Dual labels may consist of used adjacent to or of two adjacent atoms. 
Because of deuterium’s low natural abundance of 0.012%, minimal incorporation is
19
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required for detection even with a single label. Deuterium labels alone have the 
drawback of resulting in broad peaks in the NMR spectrum and exhibiting low 
sensitivity. When is adjacent to an a-isotope shift in the NMR spectrum is 
observed, so dual labeled compounds have been used to track the fate of
deuterium atoms.
An alternative tool is the incorporation of a dual label. Adjacent
labels are easily identified by a characteristic coupled doublet in the NMR spectrum. 
With a natural abundance of 1%, the natural occurrence of adjacent atoms is about
0.01%. The detection limit for incorporation is very low. The coupling giving the 
observed doublet indicates that the bond is still intact. If the bond was broken and the 
isotopes detected individually, the doublet would not be observed, so the 
observation of this labeling pattern has also been referred to as ‘bond labeling’. Bond 
labels are very useful because they supply the information about whether the labeled 
bond was broken in vivo.
Dual ^^C-labeled potential intermediates will be used to probe the nonactin 
biosynthesis pathway. Nonactin is an achiral tetramer of nonactate units. In the 
assembly of the macrocyle, both enantiomers of nonactate are required. In order to 
target a minimal number of likely intermediates to synthesize, initial target compounds 
were chosen that are close to confirmed intermediates.
In the nonactin biosynthesis pathway recentiy proposed by Priestley et al. (Figure 
12) a single ketoreductase (KR) reduces two of the carbonyls in 36, but each 
enantiomer requires its unique KR, so two KRs are required to obtain 37 and 38. The 
following transthioesterification is most likely performed by the 3-ketoacid:succinyl CoA 
CoA-transferase (TRA) encoded by orfd. The diols 39 and 40 thus obtained require two 
more ketoacyl synthases (KS) for the condensation with a methylmalonyl extender unit,
20
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one for each enantiomer. The (3-ketone of each enantiomer is then reduced by a unique 
reductase enzyme to give 43 and 44. The final steps of elimination and cyclization have 
been assigned to nonS and nonS’. This pathway would explain why there are five 
ketoacyl synthase genes and four ketoacyl reductase genes.
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Figure 14: Proposed nonactin biosynthesis
The last confirmed intermediate 6,8-dihydroxy-2-methylnon-2E-enethioate ester (54) is 
preceded by the putative intermediate 6,8-dihydroxy-2-methylnonanethioate ester (53).
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In order to establish the mechanism for the step previous to the elimination 
catalyzed by nonS/S’, the synthesis of all eight stereoisomers of thioester activated [2,3- 
’’-3,6,8-trihydroxy-2-methylnonanethioate was attempted (56).
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OH O
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OH OH
OH O
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Figure 15: Target Compounds (56)
The placement of dual ^^0 labels on carbon-2 and carbon-3 will serve to 
establish that the only modification taking place to get to the intermediate 54 is the 
elimination of the hydroxyl on carbon-3 and that the labeled bond is not broken in the 
process.
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CHAPTER 2
RESULTS AND DISCUSSION
2.1. Retrosynthetic Analysts
In our current hypothesis for the nonactin biosynthesis, the earliest and latest 
intermediates have been confirmed by feeding studies with isotopically labeled 
molecules. In order to confirm more of the biosynthesis pathway, the latest not yet 
confirmed intermediate was chosen as a synthetic target. The objective of this research 
project was to first develop a synthetic route to [2,3-’^C]-S-[2-(acetylamino)ethyl] 
(2S,3S,6R,8R)-3,6,8-trihydroxy-2-methylnonanethioate (57) that could then be readily 
adapted to synthesize the other seven stereoisomers.
Retrosynthetic analysis began with a disconnection at the thioester of 57 (Figure 
16). The fragment (58) carrying the two labels was disconnected at the labeled bond 
between 02 and 03 to yield [1-^^0]-4,6-dihydroxyheptanal (60) and [2-^^0]-propionate 
(61). Since the propionate had to be added stereospecifically, a chiral auxiliary was 
necessary. Oxazolidinones have been well-studied and show excellent stereoselectivity 
when they are used in boron-enolate coupling.'*®'®  ̂ [2-^®0]-Propionate was not 
commercially available, so it became necessary to synthesize it. In order to synthesize 
60, the anti-1,3- diol backbone had to be set up, which was the most complex feature. 
Ooupling reactions of acetoacetate esters with halides in the presence of magnesium 
chloride and an amine base, such as pyridine, have been developed as a way to set up 
asymmetric 1,3-diketones.®® It seemed to be a promising route to utilize
23
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Figure 16: Retrosynthesis of Target Molecule
the stereospecific hydrogenation developed by Noyori to reduce the asymmetric 1,3- 
diketone to the corresponding anf/-1,3-diol. As an alternative, the 1,3-dioxan-4-one 
chemistry studied by Rychnovsky was an option. Here the stereochemistry of the
1,3-diol is embedded in the dioxane, which is prepared from the corresponding 2- 
hydroxycarboxylic acid.
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2.2. Synthesis of [2-^®C]-Propionate
The synthesis of [2-’^C]-propionate was studied by two routes, tn the first case 
(Figure 17), the starting material, anisaldehyde, was converted into the corresponding
1,3-dithiane and then substituted with ethyl bromide. The label would have been 
incorporated by using [2-’ ^C]-ethyl bromide. Oxidation with m-chloroperoxybenzoic acid 
(mCPBA) and base hydrolysis yielded propionate. As an alternative, carbon dioxide was 
added to ethyl magnesium bromide in a simple Grignard reaction. In the corresponding 
labeled synthesis, [2-^^C]-ethyl bromide would have been converted into the Grignard 
reagent [2-'^C]-ethyI magnesium bromide.
H3 CO
O
hs^ " \ - ^ sh
---------------------
pTsOH
benzene 63
nBuLi/THF
65
CuO
CuClg
o
A . 64
HO
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2. NaOH, H2 O
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Figure 17: Synthesis of [2-^^C]-Propionic Acid via Dithiane
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As a classic example of an Umpolung synthon, 1,3-dlthianes have been used to 
convert aldehydes Into ketones.®^ The carbonyl in the aldehyde is electrophilic, but by 
converting it into a 1,3-dithiane, the carbon now carries a fairly acidic hydrogen. 
Treatment with a strong base, such as n-butyl lithium (nBuLi), yields the dithiane anion, 
a very nucleophilic species. The dithiane anion undergoes Sn2 substitution with 
halides.®^ Stutz and Stadler used the anion of 2-phenyl-1,3-dithiane as a nucleophile in 
addition reactions to prepare 2-alkylsulfanyl-2-phenyl-1,3-dithiane. The 1,3-dithiane was 
easily hydrolyzed to yield the corresponding ketone. Two prevalent methods are 
currently used for the regeneration of the carbonyl. Hirano et al. pioneered a 
heterogeneous cleavage reaction using Fe(N03)3-silica gel in hexanes.®'* Stutz and 
Stadler used anhydous CuClg and CuO in acetone. The latter method is known to be a 
very reliable and versatile reaction.
In this synthesis, anisaldehyde was chosen as the starting material because the 
aromatic ring chromophore made it much easier to track the progress of the synthesis by 
TLC. The formation of 63 was adopted from the standard procedure for the protection of 
diols as dioxanes.®® The yield was 65.9% which did not reflect accurately the actual 
efficiency of the reaction since a substantial amount of product was lost during the 
purification. The subsequent step of generating the anion with nBuLi and then adding 
the nucleophile was adopted from the procedure of Stutz and Stadler. The anion was 
generated at -22°C  and trapped with ethyl bromide to give the desired product 64 in 
95.9% yield. Compound 64 was cleaved to yield 65 using CuO and CuC^. Problems 
arose with the separation and purification of the product. During the aqueous base wash 
of the reaction mixture, CuCb dissolved In the aqueous phase, but CuO formed a fine 
suspension of deep orange color in the organic phase and could not be removed except 
by chromatography on silica gel. The final yield of 59.1% probably reflected that some
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of the product was lost with the CuO. This chemistry was very elegant, but the added 
steps decreased the overall yield dramatically. The overall yield for the sequence from 
anisaldehyde to 65 was 37.4%. This was particularly poor considering that the ^^C-label 
would be introduced before the reaction with the lowest yield, so most of the labeled 
compound would be lost. The sequence was not particularly amenable to scale-up. A 
larger scale preparation of 63 was attempted from which no product was isolated.
M g / THF O
' ' ^ B r  ----------------► U
CO2
67
Figure 18: Synthesis of [2-^^C]-Propionate via Grignard
In parallel to the above route, propionate was generated via a Grignard reaction. 
The nucleophilic addition of carbon dioxide to a Grignard reagent yields a magnesium 
salt that is hydrolyzed to give the corresponding acid during the work-up with aqueous 
dilute acid.®  ̂ Propionate could therefore be prepared by the addition of carbon dioxide 
to ethyl magnesium bromide. For the synthesis with the labeled starting material, the 
Grignard reagent would have to be prepared from [2-^®C]-ethyl bromide.
Dry magnesium powder in a tetrahydrofuran (THF) suspension was activated 
with a small amount of 1,2-dibromoethane. The by-product, ethene, was observed to 
bubble out of solution. Ethyl bromide was added to the activated magnesium to form 
ethyl magnesium bromide. Barium carbonate was treated with concentrated 
hydrochloric acid as a source of dry carbon dioxide. The carbon dioxide produced was 
directly channeled through a drying tube into the solution with the Grignard reagent and 
frozen out in a liquid nitrogen bath. Once the flask was sealed, it was allowed to thaw,
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thus placing the flask under a positive carbon dioxide pressure. Propionate was 
isolated by iyophilization in 86% yield. This was an efficient synthesis for [2-^^C]- 
propionate.
The major advantages of this route were that it was quick, since it involved a 
single step, and that excess carbon dioxide could be used, since it is economical and 
readily available. Iyophilization was not a quick way to remove excess solvent, but the 
procedure can be performed in a reasonable timeframe if the solvent volume is kept to a 
minimum and a good vacuum is applied. Overall, propionate was obtained in sufficient 
yield in one step.
2.3. Synthesis of Oxazolidinones
Substituted oxazolidinones were first prepared by Newman and Kutner.“  They 
developed a method to convert ketones RCOR’ into aldehydes RR’CHCHO by 
substituting 3-nitroso-2-oxazolidinones and then decomposing the oxazolidinones under 
mild conditions. In an example, methyl bromoacetate was coupled with acetone in the 
presence of activated zinc (Reformatsky reaction) to yield 68 (Figure 19). The 
corresponding hydrazide 69 was prepared by addition of hydrazine. The hydrazide was 
rearranged in the presence of nitrite to yield oxazolidinone 70. The nitroso-derivative 71 
was obtained after treatment of 70 with nitrosyl chloride. Decomposition of 71 under 
basic conditions yielded 72. In an alternative route, oxazolidinones were prepared from 
the corresponding aminoalcohol with phosgene to obtain authentic material.
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Figure 19: Newman and Kutner’s application of oxazolidinones 66
Mukaiyama studied dialkylboron trifiates to regioselectively generate Z-enolates 
(Figure 20). A ketone, such as 1 -phenylbutan-1 -one (73), was enolized with a 
dialkylboron triflate and a nitrogenous base. The borane-adduct was allowed to 
condense with an aldehyde. High stereoselectivity and regioselectivity were observed 
under these relatively mild conditions.®^ Evans continued the study of Mukaiyama-type 
boron-enolate coupling reactions and discovered that oxazolidinones were useful chiral 
auxiliaries in these reactions (Figure 21). Their major advantages were high 
enantioselectivity and their economical nature because they were easily recycled.'*® 
Initially, Evans employed the oxazolidinones derived from valinol (77) and norephredine, 
but a variety of amino alcohols have been shown to be suitable precursors.®'* The 
oxazolidinones were enolized with either lithium diisopropylamine (IDA) or dibutylboron
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Figure 20: Enoiization with dialkylboron trifiates’68
triflate to give only the Z-enolate. These enolates underwent Aldol condensations with 
various aldehydes to yield only the erythro- adduct (79) (Figure 21 ).
Since Evans began studying oxazolidinones, alternate methods for their 
preparation have been developed. Originally, Newman and Kutner employed either 
phosgene or diethyl carbonate and methoxide.®® Davies and Doisneau discovered that 
anhydrous potassium carbonate was more reliable than methoxide and since then, their 
method has become generally used.®  ̂®®
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Figure 21 : Enantioselectivity of aldol condensations with oxazolidinones
Oxazolidinones (80) readily undergo substitution at the amide nitrogen when they 
are treated with a strong base, such as nBuLi, followed by addition of an acyl halide 
(Figure 22).™ Alternatively, a mild nitrogenous base like triethylamine was used in the 
presence of catalytic 4-(dimethylamino)pyridine (DMAP) to add an anhydride.^ In this 
particular synthesis, the preparation of the labeled propionate is the limiting factor. The 
anhydride would have to be prepared with a label on both acetate groups and half of the 
labeled compound would be wasted. Therefore, the method of Ager et al. was not used.
Two different routes were studied to introduce the "C-label. In the direct route 
the oxazolidinone was substituted with propionyl chloride. The disadvantage of this 
particular synthesis is the expense of [2-^^C]-ethyl bromide. Alternatively, acétylation of
31
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
\----(  2. R2COCI \__/
80 81
1. EtgN, DMAP
0 ^ M ^ R 3
Figure 22: Substitution of Oxazolidinones ^
the oxazolidinone with acetyl chloride was explored, followed by addition of a methyl 
group. Kelly et al. used this approach to introduce ^^C-labels with [^^C]-methyl iodide in 
various positions of the propyl substituent.^^ This route had two advantages over the 
direct addition of labeled propionate. Excess methyl iodide could be used to ensure a 
complete reaction because it would be unlabeled. [2-^^C]-Acetyl chloride is significantly 
less expensive than [2-^^C]-ethyl bromide.
Methyl ester 83 was prepared from L-valine to activate the acid towards 
reduction (Figure 23). The methyl ester was reliably prepared in 85% yield. Poindexter 
and Meyers had observed that both sodium borohydride and lithium aluminum hydride 
reduced various amino acid esters to the corresponding amino alcohol under retention of 
configuration. In this sequence, 83 was readily reduced by lithium aluminum hydride 
to give 84 in over 60% yield. For the cyclization of 84 to give oxazolidinone 85, the
32
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
NH,
OH SOCI2 
MeOH
K2CO3
(EtO)2CO
1. NaH.THF 85
'  , X / ,Cl'
NH2
OMe
O
83
LIAIH4
THF
NH2
1. NaH, THF
O O G o
' I.N aH M D S.TH FO N
87
2. Me I, THF
86
Figure 23: Synthesis of (4S)-methylethyl-1,3-oxazolidinone derivatives
method of Davies and Doisneau was employed and resulted in a yield of 81%. In a 
modification of various literature preparations, 95% sodium hydride was used to 
generate the anion of 85, which was then trapped with either acetyl or propionyl chloride. 
The use of nBuLi was problematic because the anion had to be generated cold, but the 
deprotonation proceeded very slowly at low temperatures, so the reaction required 
careful modulation of time and temperature to ensure complete anion formation while 
leaving the oxazolidinone intact. With the use of 95% sodium hydride, the anion was 
reliably generated in 1 hour at 0 °C. The reaction with acetyl chloride to give 86 
proceeded rapidly and resulted in a 99.6% yield. With freshly distilled acetyl chloride the
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reaction proceeded rapidly and the product was pure as evidenced by NMR. The 
reaction of the anion of 85 with propionyl chloride to give 87 was not quite as reliable. 
The yield of 48.5% might be improved, but the hydrochloric acid content of the propionyl 
chloride would always interfere with a clean reaction. Sodium hydride was not titrated to 
accurately determine its concentration, so loss of product could be due to incomplete 
deprotonation. Overall, the reaction with propionyl chloride was less reliable than that 
with acetyl chloride.
Oxazolidinone 86 was prepared in 42.7% overall yield, which was acceptable 
because all the reactions with lesser yields occurred before the ’^C-label would be 
added. The losses would occur with unlabeled material based. Oxazolidinone 87 on the 
other hand was prepared in 20.8% overall yield. This was particularly poor because a 
50% loss occurred in the reaction in which the label was to be added, and this was the 
most expensive starting material because of the high cost of labeled ethyl bromide. 
Without major improvements in the last step, this was not a viable route.
These reactions were difficult to track since progress of all of the reactions was 
monitored by TLC. The valine-derived oxazolidinone 85 had no useful chromophore and 
was therefore hard to detect. As an alternative, norephedrine and phenylalanine were 
chosen as the starting materials since both have an aromatic ring that introduced a 
chromophore. Norephedrine is an amino alcohol, so it was cyclized directly to give the 
corresponding oxazolidinone 88 (Figure 24), as discussed in the literature.^
The preparation of 88 was analogous to the preparation of 85. The reaction was 
monitored by TLC to ensure completion, yet after recrystallization the yield was only 
56.5%. The crystals were very fine, so it is possible that some product was lost in the 
filtration. Compound 88 was treated with 95% sodium hydride, as previously 85 was in
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Figure 24: Synthesis of (4R, 5S)-3-Acety!-4-methyl-5-phenyl-1,3-oxazolidin-2-one
the synthesis of 86, to prepare 89 in 72.0% yield. This corresponds to an overall yield of 
40.7% for two steps. Norephedrine is a relatively expensive starting material compared 
to the amino acids L-valine and L-phenylalanine, so this route was not considered viable.
L-Phenylalanine has a chromophore like norephedrine. Compared to L-valine, L- 
phenylalanine is more active towards reduction, allowing direct reduction of the acid to 
the alcohol.
L-Phenylalanine was reduced with lithium aluminum hydride to give 90 in a single 
step in 69.9% yield, following the literature preparation (Figure 25).^^ While this was not 
spectacular, 84 was prepared in two steps in 52.9% overall yield from the starting 
material L-valine, so the direct reduction of L-phenylalanine was more efficient. 
Compound 90 was converted into the oxazolidinone 91 in 72.2% yield using the same 
procedure as described previously for the preparation of 85 and 88. This was an 
acceptable yield considering that this is still unlabeled material and that it was
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Figure 25; Synthesis of (4S)-4-phenylmethyl-1,3-oxazolidinone derivatives
prepared in two steps from the abundant precursor L-phenylalanine. As previously with 
85, both the acetyl and propionyl chloride substituted oxazolidinones were prepared. 
Compound 92 was crystalline and obtained in 91.1% yield. This was an excellent route, 
since 92 was prepared in 46.0% overall yield, and in an analogous labeled synthesis, the 
label would have been introduced in the highest yielding step. The méthylation proved 
difficult and proceeded in 23.1% yield. Methyl iodide was filtered through basic alumina 
to remove traces of acid that were decomposing the oxazolidinone. A large excess of 
methyl iodide was required to force the reaction. The problematic step was most likely 
the anion formation with sodium hexamethyldisiiylamide (NaHMDS). The terminal
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methyl group had to be deprotonated without cleavage of the acetyl group from the 
oxazolidinone. This reaction might be optimized further, but the literature suggested that 
there were inherent problems with this particular reaction .C om pound 93 was 
prepared in 15.2% overall yield from L-phenylalanine, with a 77% loss in the last step, in 
which the starting material would be labeled. In comparison, 93 was prepared in 86.3% 
yield from 90. By directly adding the propionyl group, 93 was prepared in 43.6% overall 
yield, with minor losses in the step in which the label would be added.
The synthesis with L-phenylalanine as a precursor for the chiral auxiliary was 
preferable to the routes based on L-valine or norephedrine as starting materials. 
Oxazolidinone 16 was prepared in 43.6% overall yield in three steps. The ’^C-label 
would be introduced in the last step and only minor losses of label would result from the 
last step. This synthesis was the most efficient, economic and reliable for the 
preparation of substituted oxazolidinones. For the labeled synthesis, this would be the 
best method.
2.4. Synthesis of 1,3-anfi-Diol “Backbone”
The anth^ ,3-diol in target molecule 57 could be synthesized by multiple different 
routes. Katsuki and Sharpless used kinetic resolution of allylic alcohols, such as 94, 
which underwent asymmetric epoxidation with a peroxide in the presence of diethyl 
tartrate and Ti(0'Pr)4 to give only one enantiomer 95 (Figure 26). '̂  ̂ The stereochemistry 
was determined by the choice of enantiomer of diethyl tartrate. The epoxide was 
opened using Red-AI® to give the anf/-1,3-diol, such as 96. Noyori pioneered a series of 
ruthenium catalysts (Figure 27) that allow stereoselective reduction of 1,3-diketones to 
give specifically the anti-1,3-diol.® '̂̂ ® Both monomeric (97) and
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Figure 26: Katsuki-Sharpless Epoxidation 74
dimeric (98) catalysts have been used. The active intermediate species is still under 
study in various laboratories.
L. Ph
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ÇI H
NEtg Cl Cl
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Figure 27: Ruthenium-binap catalysts
Rychnovsky developed an elegant method in which a single stereoisomer of a 3- 
hydroxycarboxylic acid, such as 99, was protected with pivalaldehyde as the 
corresponding 1,3-dioxane 100 (Figure 28). The stereochemistry at the second 
stereocenter was induced during the 1,3-dioxane formation.®®’®®
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Figure 28: Rychnovsky-type dioxanes 59
We Initially tried a Katsuki-Sharpless approach and attempted to synthesize 
hepta-1,5-dien-4-ol via a Grignard reaction of crotonaldehyde with allyl bromide. The 
analog octa-2,7-dien-4-ol has been prepared in this laboratory. Spontaneous elimination 
of the alcohol gave hepta-1,3,5-triene. The elimination proved difficult to suppress, since 
a conjugated system of three double bonds was formed. The route via the Katsuki- 
Sharpless epoxidation was abandoned.
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A series of 1,3-diketones have been synthesized based on the method by Rathke 
and Cowan.®® Originally, ethyl acetoacetate (103) was coupled with acid chlorides. The 
coupling has since been performed with imidazolides formed in situ as well, but it was 
observed that the reaction proceeded cleaner and more completely with acid chlorides.® 
The chlorides required in the syntheses discussed here, if they were not commercially 
available, were synthesized. The resulting esters (104) were easily deprotected to give 
the corresponding 1,3-diketone (105).
O O  ̂ o  O O O
2.RCOC, 105
104
Figure 29: Acetoacetate coupling 76
Because the ruthenium catalysts were developed recently, their full range of 
applications has yet to be explored. Kawano et al. reduced simple aliphatic 1,3- 
diketones.^^ Kitamura extended the application of the catalysts to the reduction of 
functionalized ketones.®® Noyori initially developed them for efficient stereoselective 
reduction of p-keto esters. ®̂ Since then, other research groups have experimented with 
a variety of ligands coordinated to the ruthenium center.^® In this synthesis, (+)- 
Ru(binap)(PPh3)2Cl2 (97) was used. Both enantiomers of this catalyst are commercially 
available.
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Figure 30: Synthesis of Benzyl 2-Acetyl-5-bromo-3-oxopentanoate
First, the synthesis of 106 was attempted {Figure 30). The coupling was 
performed, but 106 was never isolated. The major product of the reaction appeared to 
be benzyl 2-methyl-4-oxo-5,6-dihydro-4H-pyran-3-carboxylate (107), so the bromide had 
cyclized to form the dihydropyran ring. A strategy to avoid having such a good leaving 
group that can add intramolecularly was to have a terminal alcohol and protect it as an 
ether. The alcohol could later be converted into a good leaving group, such as a 
tosylate. Nucleophilic addition of the organocuprate formed from [2-^^C]-{2-iodovinyl)- 
benzene and subsequent ozonolysis of the double bond would yield the labeled 
aldehyde.
Compound 109 was not commercially available, so it was prepared from methyl
3-methoxypropionate (Figure 31). Hydrolysis of methyl 3-methoxypropionate with
aqueous lithium hydroxide in methanol and THF gave 108 in 72% yield. The reaction
was very good, but the disadvantage was the large volumes of solvent. Methyl 3-
methoxypropionate is insoluble in water, so the mixture of methanol and THF was
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required to dissolve the starting material. Compound 108 was converted into the 
chloride 109 in 92.9% yield. Freshly distilled 109 was used in the coupling reaction with 
benzyl acetoacetate to yield 110 in 100% yield. The progress of the reaction depended 
greatly on the purity of the starting materials. Commercially available benzyl
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Figure 31 : Synthesis of (3R,5R)-3,5-Bis-[(2.2-dimethyl)-propyl)-dimethylsilanyloxy]-1-
methoxyhexane
acetoacetate was purified by Kugelrohr distillation prior to use. Even if an excess of the
chloride was used, the high yield could not be attained when the chloride contained
impurities. The benzyl group was removed by hydrogenation to give 111 in 79.2% yield.
At the time, the reaction could not be scaled up easily because the volume of hydrogen
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required increased to the point that the balloon needed to be refilled frequently, and 
therefore the reaction proceeded slowly. The only hydrogenation apparatus available 
held a small reactor (20 mL).
The following reduction of 111 to 112 was a very sensitive process based on the 
procedure by Kitamura at al.®® The yield of 51.8% was not completely optimized. The 
reaction greatly depended on the purity and dryness of the substrate and solvent as well 
as the quality of the catalyst. At this point the catalyst was purchased from Aldrich. 
Better results were obtained later on with catalysts obtained from Strem Chemicals. The 
pressure was crucial as well. Too high a pressure resulted in loss of selectivity, too low 
a pressure resulted in Incomplete reaction. The temperature was estimated from the 
external heating bath. For later reactions, an internal temperature probe was wired in to 
allow monitoring of the actual internal temperature. All in all, this was a useful reaction, 
but it required careful control of all the variables since it was intolerant to minor changes. 
Compound 112 was protected by the procedure in Greene and Wuts to give 113 in 
100% yield.
The overall yield for this route through compound 113 was 27.4%, which was 
satisfactory for six steps. Removal of the methyl ether proved impossible without losing 
the protection of the 1,3-diol. Among the mildest conditions to remove a methyl ether 
are the methods developed by Jung and Lyster.^® They used trimethylsilyl iodide (TMS- 
I) in chloroform at 25 °C. Olah et al. pointed to shortfalls in Jung’s method and offered 
slightly modified conditions. In 6-10 hours, methyl ethers were removed by TMS-I in 
acetonitrile. Olah et al. prepared their TMS-I in s/fu from trichloromethylsilane and 
sodium iodide. In this synthesis, the methyl group could not be removed without 
removing the ferf-butyldimethylsilyl (TBS) ethers on the diol. The most common method
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for the cleavage of methyl ethers employs boron tribromide in dichloromethane but 
TBS-groups will be cleaved under these conditions.
To solve this problem a more labile ether was used instead of the methyl ether. 
Benzyl ether was chosen because it can be removed under neutral conditions, allowing 
selective removal of a benzyl ether while retaining the TBS ethers. Previous preparation 
of the methyl ether has proven that it was possible to stereoselectively reduce the 
diketone to the desired anti-^ ,3-diol.
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Figure 32: Synthesis of 1-Phenylmethoxyhexa-3,5-dione
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Since 3-(phenylmethoxy)-propionyl chloride was not commercially available, it 
was synthesized (Figure 32). Acrylonitrile and benzyl alcohol were reacted by the 
method of Gutman et al.®̂  to give 114 in 99.0% yield. The reaction was very robust 
and clean. Hydrolysis of the nitrile in 114 to give 115 was achieved with potassium 
hydroxide in 30% hydrogen peroxide. This reaction gave the product in 29.8% yield, but 
milder alternative methods failed to hydrolyze 114. A major problem with this reaction 
was that it was quite exothermic at first, so when the substrate 114 was dissolved in 
hydrogen peroxide and aqueous potassium hydroxide was added, the reaction mixture 
heated up. The temperature usually stabilized around 65 ®C, but with larger scale 
reactions it proved difficult to keep the vessel cool enough to prevent the reaction from 
getting out of control and yet let it warm up enough to allow the reaction to proceed.
The acid 115 was converted into the chloride using thionyl chloride according to 
the procedure by Li et a\7^ An alternative route to prepare 3-(phenylmethoxy)-propanoyl 
chloride with oxalyl chloride and catalytic DMF was reported by Eberlein, West and 
Tester.®® Crude 3-(phenylmethoxy)-propanoyl chloride was directly used to prepare 116 
in 71.6% yield. The terf-butyl ester was cleaved with trifluoroacetic acid (TFA) in 
dichloromethane using the method of Bryan et al.®̂  Only 13.2% of the product 118 was 
obtained. This was likely due to decomposition, so a different ester that could be 
deprotected under milder conditions should work better. As the immediate analogue, the 
corresponding benzyl ester 117 was prepared from 115. As reported previously, 115 
was converted in situ into 3-(phenylmethoxy)-propanoyl chloride and coupled with benzyl 
acetoacetate to give 117 in 67.7% yield.
To remove the benzyl ester in the presence of a benzyl ether required a more 
specific catalyst than previous hydrogenations. Sajiki et al. reported an 
ethylenediamine-doped palladium catalyst that could selectively remove benzyl esters in
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the presence of other functionalities sensitive to hydrogenation.®® The reaction was run 
under the same conditions as previous hydrogenations, at room temperature under a 
balloon with hydrogen. Compound 118 was prepared in 95.7% yield using this method.
The benzyl ester was prefered over the ferf-butyl ester since it was removed 
under very mild conditions. The preparation of 118 via the ferf-butyl ester resulted in an 
overall yield of 2.7%, so this route was abandoned. Compound 118 was prepared in 
19.1% overall yield from acrylonitrile and benzyl alcohol, which is satisfactory. Previous 
to the nitrile hydrolysis, which was the only low yield step, only readily available reagents 
had been used in the reaction making it amenable to scale-up.
Problems arose with the hydrogenation of 118 to give (3R,5R)-1- 
phenylmethoxyhexa-3,5-diol. The substrate 118 was either not reduced completely or 
the terminal benzyl group was removed as well. The catalyst (97) was reported to be 
selective enough to not hydrogenate benzyl ethers, yet the only systems it had been 
used with were aliphatic 1,3-diketones with a phenyl group or simple esters such as 
ferf-butyl or methyl.®® The common method for the removal of benzyl ethers is 
hydrogenation in the presence of palladium on carbon in ethanol,®® Therefore, the 
hydrogenation was unlikely to proceed without removal of the benzyl group even if 
optimized. At this point an alternate strategy appeared to be a better solution to the 
problem.
Instead of looking at other ethers to protect the alcohol, the terminal bromide 
could be obtained by functional group interconversion from the aldehyde. Aldehydes are 
easily formed by ozonolysis of an alkene. Subsequent reduction and introduction of the 
bromide with triphenylphosphonium bromide would yield the terminal bromide. 
Vinylacetic acid was commercially available, so the chloride could be prepared and used 
in the coupling as previously.
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Figure 33: Synthesis of (2,2-Dimethyl)-propyl 2-acetyl-3-oxohex-5-enoate
3-Butenoyl chloride was prepared by adding oxalyl chloride to neat vinylacetic 
acid. During the first few reactions, 3-butenoyl chloride was prepared according to the 
method of Marson, Grabowska and Fallah using thionyl chloride. The product was 
impure, so it was isolated and purified, but this is a highly corrosive compound that is 
difficult to handle and does not store well even at low temperatures. Therefore, it was 
prepared in situ using the much cleaner reaction conditions of oxalyl chloride, and 
directly used in the coupling reaction to give 119 in 48.7% yield (Figure 33). Although 
this yield was not as good as yields previously attained in this reaction, it was sufficient 
to make substantial amounts of 119.
Problems with this reaction appeared in the hydrogenation of 119 when hept-5- 
ene-2,4-dione (120) was obtained instead of hept-6-ene-2,4-dione (121). The double 
bond always rearranged into conjugation with the 1,3-diketone. This type of compound
had been the focus of an investigation by Linstead and Williams. They found these
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systems prone to rearrangement and as predicted, the rearrangement was observed to 
occur in a reaction very similar to the one attempted here. Linstead and Williams solved 
the problem by using styrylacetic acid instead of vinylacetic acid. The phenyl group in 
conjugation with the double bond prevented the rearrangement.
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Figure 34: Synthesis of 7-Phenylhept-6-ene-2,4-dione
Since 4-phenyl-3-butenoyl chloride was not commercially available, it was 
prepared by the method of Hoye and Richardson (Figure 34).®® An alternate method by 
Kumar et al.®° used silica gel as a catalytic surface and microwave radiation. Although 
this approach was tried, the method of Hoye and Richardson proved more reliable and 
consistently produced 122 in 65.6% yield.
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The chloride was prepared from 123 with oxalyl chloride In ether. This was the 
first chloride prepared that was a solid at room temperature, so it was recrystallized 
before using It in the coupling reaction. After recrystallization, the chloride was only 
produced in 40.6% yield, but since both malonic acid and phenylacetaldehyde are 
readily available, the method was not optimized. The coupling reaction produced 123 in 
89.1% yield. The ferf-butyl ester was cleaved with trifluoroacetic acid In 
dichloromethane.®® This system proved good enough to yield 88.0% of 124 after 
treatment with acid.
Overall, this was a solid route with 20.9% overall yield in 4 steps. All the steps 
with low yield involved only inexpensive reagents in the early part of the synthesis. The 
problematic step was the reduction of 124 to give 1-phenylheptene-4,6-diol. The product 
was lacking the double bond, so the alkene was saturated in the hydrogenation. Ohta et 
al. had used ruthenium-binap catalysts in the asymmetric reduction of alkenes.^’ The 
conditions to reduce the 1,3-diketone were forced, so the alkene was probably saturated 
at the same rate as the carbonyls were reduced. Selective reduction of the 1,3-diketone 
over the alkene seemed impossible.
Phenyl rings have been used as latent carboxylic acids because they are very 
unreactive, so most common functional group interconversions do not affect phenyl 
rings. Since ruthenium tetraoxide was introduced as an oxidant for a variety of oxidation 
reactions in 1953 by Djerassi and Engle it has been used in catalytic systems 
involving periodate or hypochlorite as oxidants. Traditionally, about 1-5% of ruthenium 
catalyst was added to the substrate in carbon tetrachloride and water,®'’ but these 
reactions were frequently slow or failed if the substrate included a carboxylic acid or if an 
acid was formed by the oxidation, since the ruthenium catalyst forms carboxylate 
complexes and therefore loses activity. Carlsen et al.®̂  modified the procedure to a
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biphasic solvent system of carbon tetrachloride, water and acetonitrile to make it more 
amenable to the oxidation of phenyl rings. Additionally, a large excess of metaperiodate 
was used with ruthenium trichloride hydrate to be able to oxidize phenyl rings. This has 
now become the most commonly used m e th od .N une z  and Martin modified the 
procedure by using periodic acid instead of metaperiodate, since the metaperiodate 
tends to form a precipitate that has been shown to prevent the reaction from going to 
completion.
Although not used as frequently, ozonolysis can be used to decompose the 
aromatic ring. The work-up determines the final product. Oxidative work-up with 
hydrogen peroxide yields the acid. Reductive work-up with sodium borohydride should 
yield the alcohol, but in the literature only the oxidative work-up has been used, followed 
by borane reduction to give the alcohol.®^
Since phenylacetyl chloride was commercially available, it was coupled with 
benzyl acetoacetate to give 125 in 74.0% yield (Figure 35). The benzyl ester was 
removed by hydrogenation to give 126 in 74.4% yield. The 1,3-diketone was reduced to 
127 under 52 atm of hydrogen pressure. The reaction proceeded slowly, taking 3 days, 
but it was determined that with a shorter reaction time, significant amounts of 
monoreduced substrate were recovered, which were difficult to separate from 127. After 
the full reaction time of 3 days, the product was obtained in 92.2% yield.
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Figure 35: Synthesis of (3R,5R)-3,5-Diacetyloxyhexanol
The TBS-protection used so far was unsuitable for the oxidation reaction, so a 
more robust protective group was needed. Dioxanes are very stable, so the diol was 
protected as the 1,3-dioxane with 2,2-dimethoxypropane. The reaction required lengthy 
reflux to go to completion and a substantial amount of 127 degraded. The product 128 
was only obtained in 45.7% yield.
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As an alternative, 127 was protected as the diacetate. Initially, the procedure of 
Robinson et al.'̂  ̂was followed, but long reaction times and moderate yields called for 
improvement. Hofle et al.®® reported that acétylation reactions proceeded up to 10'* 
times faster in the presence of catalytic 4-(dimethylamino)pyridine (DMAP) compared to 
running the reaction only with pyridine. The modified procedure with DMAP worked well 
and 129 was prepared in 66.1% yield in 2 hours.
The ozonolysis of 129 to give 130 followed the procedure of Bednarski and 
Danishefsky.®^ It was run at room temperature which is an unusual feature. Ordinarily, 
ozonolyses are done at -78 °C. In order to keep the solvent from evaporating the flask 
was equipped with a dry ice trap. Acid 130 was purified by column chromatography and 
obtained in 23.2% yield. This yield did not reflect the efficiency of the actual reaction 
because some of the product was lost on the column. Sometimes 1% acetic acid was 
used as an additive to the eluent, but the acetic acid was difficult to remove completely. 
Most of the time the crude extract was directly used in the borane reduction, as 
Bednarski and Danishefsky had done. The borane reduction was problematic. Product 
131 was only obtained in 13.5% yield, which was very poor. Borane was purchased as 
a solution and not titrated, so there was no guarantee for its actual concentration and 
purity. This reaction has only been run on a fairly small scale due to limited amounts of 
130, so any discrepancies in the concentration of borane and any impurities in the 
substrate 130 had a major impact on the final yield.
Compound 129 was prepared in 33.6% overall yield in four steps. This was very 
promising, especially since the following two steps are proven to work. They only 
require some further optimization, which has not been done due to time constraints. In 
parallel to the above synthesis, the analogue based on 3,4-dimethoxyphenylacetyl 
chloride was prepared. The ozonolysis proceeded very slowly, so activation in the form
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Figure 36: Synthesis of (2R,4R)-1-(3,4-Dimethoxyphenyl)-penta-2,4-dlol acetate
of substituents on phenyl ring was assumed to Improve this reaction. As a commercially
available precursor, 3,4-dimethoxyphenylacetyl chloride was chosen.
This route proceeded much like its analogous preparation of 129 (Figure 36).
3,4-Dimethoxy-phenylacetyl chloride was coupled with benzyl acetoacetate to give 132
in 76.3% yield. Hydrogenation of the benzyl ester and decarboxylation resulted in 133 in
91.1% yield. The 1,3-diketone 133 was reduced to 134 under 82 atm of hydrogen. This
reaction went slower than previous reductions with the ruthenium catalyst. A reaction
time of 5 days was required to force the reaction to go to completion, compared to a
reaction time of 3 days to prepare 127. Product 134 was isolated in only 48.6% yield. A
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problem with this reaction was the high pressure and long reaction time required since 
the high pressure reduced selectivity. The catalyst was of good quality and was used for 
both 127 and 134, resulting consistently in high yields of 127 and mediocre yields of 134. 
The diacetate was prepared by Spavold’s route‘* \ so 134 was simply stirred in pyridine 
and acetic anhydride added cold. The product 135 was isolated in 21.3% yield.
Compound 135 was prepared in 7.2% overall yield from 3,4-dimethoxy­
phenylacetyl chloride and benzyl acetoacetate. The ozonolysis of 135 proceeded 
slightly faster than that of 129. Still, the slight gain was not worth the loss of material 
and the longer reaction time for the reduction experienced with this particular route. The 
substitution of the phenyl ring seemed to make the 1,3-diketone 133 less active towards 
reduction to 134. It was interesting to test an alternative substrate to make 131, but this 
proved to be an inferior route.
At this point, it was worthwhile considering whether the introduction of the 
labeled carbon as cyanide would make the process easier (Figure 37). The nitrile was 
then to be hydrolyzed to give the acid that could be converted into the aldehyde.
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138 O
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139
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Figure 37: Retrosynthesis - introduction of labeled cyanide
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3-Cyanopropionic acid 143 has been prepared in one step from p-propiolactone 
by ring-opening with sodium cyanide, as reported by Gresham et al. (Figure 38).®® The 
acid was easily converted into 3-cyanopropionyl chloride with thionyl chloride in ether by 
Dolby et al.’°°
I f  NaCN X
O EtOH / HgO NC
143
Figure 38: Literature preparation of 3-cyanopropionic acid 99
p-Propiolactone is an undesirable starting material because it tends to polymerize upon 
storage and cannot be purchased in large quantities. The alternative of using 3- 
bromopropionic acid as the starting material was explored.
O
MeOH
HO Br H2SO4 MeO ^  Br
144
KCN
EtOH / H2O 
O LiOH O
HO CN -  MeO ^  CN
143 145
Figure 39: Synthesis of 3-cyanopropionic acid
Cyanide was added in a simple nucleophilic displacement to 144 (Figure 39).
The most common method is to use sodium or potassium cyanide in aqueous ethanol.
Alternatively, lithium cyanide has been used in THF. Lithium cyanide has the advantage
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that it is soluble In THF and more reactive than potassium cyanide/°^ Lithium cyanide 
has been prepared from acetone cyanohydrin.’®̂ In this synthesis, the standard method 
of treatment with potassium cyanide in aqueous ethanol was chosen.
3-Bromopropionic acid was esterified with methanol and catalytic sulfuric acid by 
the same method as L-valine to yield 144 in 85.2% yield. Just as before, this was a 
good reaction. After trying different solvent mixtures for the nitrile synthesis, it appeared 
that ethanol:water (1:1) works best. For safety, the potassium cyanide was weighed out 
into a preweighed flask in the hood and the amount of substrate was adjusted 
accordingly. Only 28.4% of 145 was obtained. Part of the problem appeared to be that 
145 was somewhat soluble in water, so some of the material was never recovered in the 
extraction. Hydrolysis under basic conditions, similar to the hydrolysis of methyl 3- 
methoxypropionate previously, yielded 43.5% of the product 143. The problem of 
solubility increased in this step. Compound 143 was very soluble in water, so the 
mixture was concentrated to minimal solvent and extracted with copious volumes of 
ether to assure that as much of the product as possible was recovered.
This route has not been pursued in enough depth to make predictions about its 
viability. The displacement with cyanide to give 145 needs drastic improvements before 
this should be considered an alternative to the route via 131.
As a radical departure from the acetoacetate ester coupling, a dioxane was 
synthesized to set up the backbone of target molecule 57 (Figure 40). Rychnovsky®® 
began studying dioxanes as a general way to construct the framework of anti-^ ,3- diols 
based on prior work by Seebach et The dioxanes readily underwent coupling
with dialkylzinc reagents to elongate the chain. The dioxane was stable enough to allow 
other functional group modifications to take place.
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Figure 40: Synthesis of 2-(1,1 -Dimethylethyl)-6-methyl-1,3-dioxan-4-yl acetate
The backbone of target molecule 57 dictated the use of 3-hydroxybutyric acid as 
starting material which was prepared from benzyl acetoacetate (Figure 40). Racemic 
146 was obtained by reducing benzyl acetoacetate with sodium borohydride (NaBH4). 
The procedure was slightly modified from the one by Nelson® and gave 146 in 99.9% 
yield. Alternatively, hydrogenation of benzyl acetoacetate in the presence of (+)- 
Ru(binap)(PPh2)2Cl2 (97) according to Noyori et al.®̂  gave the pure R-enantiomer of 146 
in 100.0% yield. The hydrogenation was forced with 82 atm hydrogen over a reaction 
time of 36 hours. Since there was no other reaction possible, the product was obtained 
quite pure out of the reaction mixture. The ester had to be hydrolyzed in a nonaqueous
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system since 147 was very water-soluble and difficult to isolate from an aqueous extract. 
Benzyl acetoacetate is relatively expensive compared to, for example, methyl 
acetoacetate, but the reduction and hydrolysis of methyl acetoacetate yielded only 
insignificant amounts of 147. The benzyl ester was easily removed by hydrogenation in 
the presence of palladium on carbon because it was done under non-aqueous 
conditions. The hydrogenation resulted in a yield of 97.4% of 147.
Compound 147 was efficiently prepared from benzyl acetoacetate in 97.3% 
overall yield. The problems with this route started with the protection of 147. Initially, 
the procedure of Rychnovsky et al.®® was adopted, where the hydroxyl-groups were first 
protected as the corresponding trimethylsilyl ethers with trimethylsilyl chloride and 
triethylamine. The resulting product was distilled at 70 °C (0.2 torr) and treated with 
pivalaldehyde, 2,6-lutidine and trimethylsilyl triflate. This reaction showed no trace of 
product. Seebach et al.®° protected 3-hydroxybutyric acid with pivalaldehyde in the 
presence of pyridinium p-toluenesulfonate (PPTS). In a different communication, Powell 
and Rychnovsky utilized scandium triflate and molecular sieves to achieve the same 
reaction. Following Powell and Rychnovsky’s procedure, only 26.1% of the product 148 
was obtained. The reaction was very sensitive, so the solvent was freshly distilled and 
dry, the molecular sieves were dried in an Abderhalden apparatus, and both 147 and the 
pivalaldehyde were freshly distilled. The quality of the scandium triflate was never 
ascertained, but when the alternative procedure by Seebach et al. was followed, freshly 
recrystallized and dried pyridinium p-toluenesulfonate (PPTS) was used and the reaction 
nevertheless did not go any cleaner or better. In the subsequent reaction 148 was 
reduced by dibutylaluminum hydride (DIBALH) and treated with acetic anhydride to give 
149 in 16.9% yield. At this point, this route was abandoned.
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A major problem arose vwth the use of pivalaldehyde, which was synthesized. 
Pivalaldehyde Is very volatile and unstable, so It should only be stored short-term and 
frozen. The synthesis proved difficult not in producing pivalaldehyde but rather in 
isolating It. The continuous supply of pivalaldehyde began to be a problem because it 
has a low molecular weight and Is used In excess In the protection reaction. 
Pivalaldehyde was most successfully produced by oxidation of neopentyl alcohol with 
bichromate according to Vogel’s p r o c e d u re .T h e  aldehyde was continuously distilled 
out of the reaction mixture for a yield of 31%. The only other method with any promise 
was published by NazarkI et al.̂ °® The Grignard reagent of ferf-butyl chloride was 
formed and dimethylformamlde (DMF) added as a formate donor. The resulting reaction 
mixture was stabilized with hydroqulnone. Pivalaldehyde was distilled out to give a yield 
of 13.1%. In light of the promise shown by the acetoacetate coupling reactions and the 
problems encountered early on In this particular route, this synthesis was abandoned.
2.5. Conclusions
The synthetic route via 131 showed the most promise In the preparation of the target 
molecule 57. The alternate syntheses have been shown to fall. In order to complete the 
synthesis and prepare 57, the alcohol 131 will have to be converted Into either the Iodide 
150 or the tosylate to provide a good leaving group. This leaving group will be 
substituted by ’^C-labeled potassium cyanide to give nitrile 151. Before hydrolyzing 151 
to the corresponding acid 152, it will be necessary to exchange the acetate protecting 
groups on the 1,3-diol for tert butyldlmethylsllyl (TBS) ethers. The acid will then be 
reduced to the aldehyde 153 by DIBALH. Alternatively, the acid could be reduced to the 
alcohol and then oxidized to 153 via a Swem oxidation. The aldehyde 153 will be
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coupled with the oxazolidinone in an Evans-a\ào\ reaction to give the acid 154. The acid 
is easily converted into the W-caprylcysteamine thioester 57, which is fed into the 
fermentative culture.
There is still much work to be done, but hopefully the synthetic route described in 
this thesis will proved useful in directing future studies.
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Figure 41 : Future Work
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CHAPTER 3
EXPERIMENTAL SECTION
General Procedures
Solvents were purchased from Fisher Scientific. All other chemicals, unless 
noted otherwise, were obtained from Aldrich Chemical Co (Milwaukee, Wl). The 
Ru(binap)(PPh2)2Cl2 catalyst was purchased from Strem Chemicals (Newburyport, MA). 
The solvents CH2CI2 (over CaH2>, Et20 (over Na/K-benzophenone), THF (over Na/K- 
benzophenone), and MeOH (over Me(0 Me)2) were dried and distilled prior to use. 
Solutions were dried over anhydrous MqSGa and concentrated by evaporation in vacuo. 
All synthesis procedures were carried out under a slight positive pressure of dry argon 
gas. Column chromatography was performed with Silicycle Ultra Pure Silica Gel 230- 
400 Mesh (Quebec, QC, Canada). IR spectra were acquired on a Nicolet Nexus 870 
FT-IR. NMR spectra were acquired on a Varian Unity 400 MHz, were referenced to 
residual solvent, and are reported as chemical shift (5/ppm), intensity, splitting pattern, 
and coupling constant (J/Hz).
Synthesis
63 2-(4-Methoxyphenyl)-1,3-dlthlane; Anisaldehyde (3.0 mL, 25.0 mmol), p-tosic 
acid (0.24 g, 1.25 mmol), and 1,3-propanedithiol (7.5 mL, 75.0 mmol) were 
dissolved in benzene (61 mL) and heated at reflux overnight in a flask equipped 
with a Dean-Stark trap. The mixture was concentrated and gave a yellow solid,
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which was crystallized from benzene-EtaO to yield white crystals (3.73 g, 65.9%). 
Mp 114-116 °C (benzene-EtzO); IR (ATR): 1506 (s), 1247 (s), 1029 (s), 757 (m), 
674 (m) cm '\
64 4-(2-Ethyl-1,3-dithlan-2-yl)-1-methoxybenzene: A solution of n-BuLi (8.0 mmol) 
in hexanes (3.2 mL) was carefully added by syringe into a stirred solution of 63 
(1.81 g, 8.0 mmol) in dry THF (100 mL) at -22  °C. After 15 min EtBr (0.37 mL,
5.0 mmol) was added by syringe and the reaction left stirring overnight, allowing it 
to warm to 15 °C. The reaction was quenched with aq. sat. NH4CI (15 mL) and 
extracted with EtgO (3x50 mL). The extracts were combined, dried, filtered, and 
concentrated. The crude yellow oil obtained was purified by chromatography on 
silica gel, eluting with EtOAc-hexanes (1:3), to give a clear liquid (1.22 g, 95.9%). 
'H NMR (400 MHz, CDCI3) Ô 7.80 (2H, d, Jih-ih = 7.9 Hz), 6.65 (2H, d, Jih-ih = 7.9 
Hz), 3.83 (3H, s), 2.68 (4H. m), 2.04 (2H, q, Jm-iH = 7.1 Hz), 1.93 (2H. m), 0.81 
(3H, t, = 6.7 Hz); NMR (100 MHz. CDCI3) Ô 181.9, 158.4, 133.8, 130.1, 
113.8, 55.7, 38.0, 17.9, 16.8, 8.5.
65 1-(4>Methoxyphenyl)propan-1-one: A solution of 64 (1.78 g, 7.0 mmol) in dry 
acetone (14 mL) was slowly added to a suspension of CuO (0.69 g, 8.4 mmol) 
and anhyd. CuCb (2.25 g, 16.8 mmol) in dry acetone (56 mL) and DMF (1.4 mL) 
at reflux. After 2 h the orange precipitate was removed by filtration and washed 
with CH2CI2 (70 mL). The organic fractions were combined and washed with 2 M 
Na2C03 (70 mL), followed by aq. sat. NaCI (50 mL). The combined extracts were 
dried, filtered, and concentrated to give a dark-red liquid that was purified by 
chromatography on silica gel, eluting with EtOAc-hexanes (1:3), to give the
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product as a pale orange liquid (0.68 g, 59.1%). ’ H NMR (400 MHz, CDCU) 5 
7.82 (2H, d, JiH-iH = 7.8 Hz), 6.86 (2H, d, Jih-ih = 7.8 Hz), 3.81 (3H, s), 2.88 (2H, 
q. Jih-ih = 6.9 Hz), 1.19 (3H, t, Jm-w = 6.5 Hz); NMR (100 MHz, CDCI3) 5
198.7, 163.0, 130.1, 129.9, 113.8, 54.4, 31.2, 8.3.
67 Sodium propanoate: 1.2-Dlbromoethane (5 pL) was added to a stirred
suspension of Mg (0.5 g, 20.0 mmol) in dry THF (20 mL). After gas evolution 
stopped, distilled EtBr (0.75 mL, 10.0 mmol) was added via syringe. Dry CO2 was 
generated from BaCOs (9.9 g. 50.0 mmol) and HCI (5 M, 10 mL). The Ar 
atmosphere was replaced with CO2, which was passed through a drying tube.
The reaction was left stirring overnight at rt. The mixture was quenched with 1 M 
NaOH (20 mL) and extracted with EtaO (2x20 mL). The pH of the aqueous layer 
was adjusted to 1.5 with 1 M HCI. Propionic acid and H2O were isolated by 
lyophilization. The pH of the collected lyophilizate was adjusted to 6.5 and H2O 
was removed by lyophilization, leaving sodium propionate (0.69 g, 86.0 %). IR 
(ATR): 1553 (s), 1368 (s) cm \  'H NMR (400 MHz, D2O) 6 2.2 (2 H, q, = 7.8 
Hz), 0.9 (3H, t, J1H-1H = 7.8 Hz); NMR (100 MHz, D2O) Ô 186.6, 31.7, 11.2.
83 (S)-Methyl 2-amino-3-methylbutanoate: Distilled SOCI2 (14.6 mL, 0.2 mol) was 
added dropwise to a stirred suspension of L-Valine (11.7 g, 0.1 mol) in dry MeOH 
(250 mL) at 0 °C. The reaction mixture was heated to reflux. After 19 h the 
mixture was allowed to cool to rt and quenched by pouring onto ice (300 mL).
The pH was adjusted to 10 with aq. c. NH4OH. The mixture was extracted with 
CH2CI2 (3x100 mL). The extracts were combined, dried, filtered, and 
concentrated. The crude product was distilled to give a colorless oil (11.05 g,
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85.5%). Bp 47-49 °C (35 torr); IR (ATR): 1729 (s) cm \  'H NMR (400 MHz.
CDCI3) Ô 3.57 (3H, s), 3.14 (IN . d, Jih-ih = 6.0 Hz), 1.86 (1H. m), 1.28 (2H, s).
0.82 (3H. d, = 4.0 Hz), 0.76 (3H, d, Jih-ih = 3.9 Hz); NMR (100 MHz, 
CDCI3) 6 176.0, 60.6, 52.6, 33.3, 20.4, 18.1.
84 (S)-2-AmmO"3-methylbutan-1-ol: A solution of 83 (19.0 g, 147 mmol) in dry THF
(50 mL) was added dropwise into a stirred suspension of LiAIH4 (11.2 g, 294 
mmol) in dry THF (500 mL) at 0 ®C. After 30 min, H2O (11.2 mL) was added very 
carefully, followed by 15% (w/v) aq. NaOH (11.2 mL) and then H2O (33.6 mL).
The mixture was stirred vigorously for 30 min and the white solid that was formed 
removed by filtration. The filtrate was concentrated and the crude product distilled 
to give a colorless oil (9.4 g, 61.9%). Bp 114-116 °C (36 torr); ^H NMR (400 MHz, 
CDCI3) 6 3.19 (1H, m), 2.90 (1H, t, Jih-ih = 9.1 Hz), 2.65 (1H, brs), 2.16 (1H, m),
1.21 (1H, m), 0.51 (6 H, q, Jih-ih = 5.3 Hz); NMR (100 MHz, CDCI3) Ô 63.3,
57.6, 29.9, 18.5, 17.6.
85 (4S)-4-(1>Methylethyl)-1,3-oxazolidin>2-one: Anhyd. K2CO3 (0.14 g, 1.0 mmol) 
was added to a solution of 84 (2.36 mL, 20 mmol) in (EtO)2CO (4.8 mL, 40 mmol). 
The reaction mixture was fractionally distilled through a Vigreux column to leave a 
yellowish solid. The solid was purified by crystallization from toluene and 
recrystallization from hexanes as white crystals (2.09 g, 81.0%). Mp 67-69 °C 
(hexanes); ^H NMR (400 MHz, CDCI3) Ô 6.68 (1H, s), 4.43 (1H, t, Jih-ih = 9.0 Hz), 
4.08 (1H, m), 3.59 (1H, m), 1.74 (1H, m), 0.94 (3H, d, Jih-ih = 7.0 Hz), 0.85 (3H, d,
= 6.4 Hz); NMR (100 MHz, CDCI3) Ô 154.0, 69.9, 59.5, 33.8, 19.3, 18.8.
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86 (4S)-4-(Methylethyl)-3-acetyl-1,3-oxazolidinone; Dry 85 (2.58g, 20.0 mmol) 
was added Into a stirred suspension of 95% NaH (0.58 g, 24.0 mmol) in dry THF 
(40 mL) at 0 ®C. After 1 h AcCI (1.4 mL, 20.0 mmol) was added via syringe. After 
1 h the mixture was allowed to warm to rt and stirred overnight. The reaction was 
quenched by the addition of aq. sat. NH4CI (10 mL) and the organic phase 
extracted with EtgO (3x50 mL). The extracts were combined, dried, filtered, and 
concentrated to give a clear liquid (3.41 g, 99.6%) that was used without further 
purification. IR (ATR): 1779 (s), 1701 (s), 1375 (s), 1303 (s), 1206 (s) cm '; 'H 
NMR (400 MHz, CDCI3) Ô 4.36 (1H. m), 4.20 (2H, m). 2.46 (3H, s), 2.32 (1H, m), 
0.67 (3H, d. = 6.7 Hz), 0.60 (3H. d, Jih-ih = 6.7 Hz); NMR (100 MHz, 
CDCI3) 5 170.2, 154.1, 63.1, 58.2, 28.5, 24.0, 18.1, 14.9.
87 (4S)-4>(1-Methylethyl)-3-propanoyl-1,3-oxazolidin-2-one: A solution of dry 85 
(0.52 g, 4.0 mmol) In dry THF (2.0 mL) was added carefully to a stirred 
suspension of 95% NaH (0.12 g, 4.8 mmol) in dry THF (2.0 mL). After 20 min, 
propionyl chloride (0.26 mL, 4.0 mmol) was added by syringe and the reaction 
stirred overnight. The mixture was quenched with aq. sat. NH4CI (5 mL) and 
extracted with CH2CI2 (3x10 mL). The extracts were combined, dried, filtered, 
and concentrated. The crude yellow oil obtained was purified by chromatography 
on silica gel, eluting with EtOAc-hexanes (1:1), to give a pale liquid (0.36 g, 
48.5%). ’ H NMR (400 MHz, CDCI3) 6 4.39 (1H, m), 4.19 (2H, m), 2.89 (2H, m), 
2.32 (1H. m), 1.12 (3 H, t, Jih-ih = 8.0 Hz), 0.87 (3H, d, Jih-ih = 4.0 Hz), 0.83 (3H, 
d, = 6.4 Hz); NMR (100 MHz, CDCI3) 6 174.0, 154.0, 63.2, 58.5, 26.7,
26.1, 18.0, 14.4, 8.5.
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88 (4/?, 5S)-4-Methyl-5>phenyioxazoiidin-2-one: Anhyd. K2CO3 (0.14 g, 1.0 mmol)
was added into a solution of norephedrine (1.51 g, 10.0 mmol) in dry (EtO)2CO 
(3.0 mL, 25.0 mmol). The reaction mixture was heated to 150 °C for 3 h and 
MeOH removed by distillation. The mixture was allowed to cool and then 
concentrated. The residue was dissolved in CH2CI2 (10 mL) and washed with 
H2O (2x10 mL). The organic layer was dried, filtered, and concentrated to give a 
white solid. After crystallization from EtOAc-hexanes, white crystals were 
obtained (1.00 g, 56.5 %). Mp 113-115 °C (EtOAc-hexanes); IR (ATR): 3264 (b), 
1713 (s) cm ’ ; ’ H NMR (400 MHz, CDCI3) Ô 7.21 (5H. m), 5.79 (IN, brs), 5.70 
(1H, d, Jih-ih = 6.6 Hz), 4.18 (1H, m), 0.79 (3H, d, Jih-ih = 4.0 Hz); NMR (100
MHz, CDCI3) Ô 153.2, 134.6, 128.2, 126.0, 80.7, 52.3, 17.6.
89 {4R, 5S)-3-Acetyl-4-methyl-5-phenyl-1,3-oxazolidin-2-one: Compound 88
(0.89 g, 5.0 mmol) was added into a stirred suspension of 95% NaH (0.14 g, 6.0 
mmol) in dry THF (10 mL) at 0 °C. After 3 h, AcCI (0.4 mL, 5.0 mmol) was added 
via syringe. The reaction mixture was stirred overnight at rt. The reaction mixture 
was quenched by the addition of aq. sat. NH4CI (5 mL) and extracted with Et20 
(3x5mL). The extracts were combined, dried, filtered, concentrated, and purified 
by chromatography on silica gel, eluting with EtOAc-hexanes (1:3), to give a clear 
liquid (0.78 g, 72.0 %). ’H NMR (400 MHz, CDCI3) 5 7.35 (5H, m), 5.63 (1H, d, 
JiH-iH = 7.7 Hz), 4.72 (1H, m). 2.49 (3H, s), 0.83 (3H, d, Jih-ih = 5.2 Hz); NMR 
(100 MHz, CDCI3) Ô 176.1, 170.0, 152.6, 132.8, 128.3, 125.9, 78.4, 54.2, 24.0.
14.1.
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90 (2S)-2-Amino>3-phenylpropan-1-ol: A slurry of L-phenylalanine (8.26 g, 50.0 
mmol) in dry THF (50 mL) was dropped slowly Into a slurry of LIAIH4 (3.80 g,
100.0 mmol) in dry THF (150 mL) at 0 °C. The mixture was stirred for 2 h at 0 °C, 
then 2 h at rt. Finally, it was heated at reflux for 20 h. The reaction mixture was 
cooled to 0 °C and quenched by the addition of H^O (3.8 mL), 15% (w/v) NaOH 
(3.8 mL) and then H2O (11.4 mL). The resulting precipitate was stirred for 30 min 
before being collected by filtration and washed with EtgO (100 mL). The 
combined filtrate and washes were concentrated to give a yellow solid, which was 
crystallized from benzene to give white crystals (5.28 g, 69.9 %). Mp 84-88 °C 
(benzene): IR (ATR): 3356 (s), 3298 (b), 1576 (s), 1064 (s) cm*'; 'H NMR (400 
MHz, CDCI3) Ô 7.21 (5H, m), 3.61 (1H, dd, -  3.2 Hz, 7.9 Hz), 3.37 (1H, q,
= 5.8 Hz), 3.10 (1H, m), 2.79 (1H, dd, Jih-ih = 2.7 Hz, 13.3 Hz), 2.53 (1H, q, 
J1H-1H = 8.0 Hz). 2.17 (3H. br s); NMR (100 MHz, CDCI3) Ô 158.2, 128.6,
128.3, 126.2, 66.0, 54.1, 40.9.
91 (4S)>4-Phenylmethyl-1,3-oxazolidin-2-one: Anhyd. K2CO3 (0.28 g, 2.0 mmol) 
was added to a solution of dry 90 (3.02 g, 20.0 mmol) in dry (EtO)2CO (6.1 mL,
50.0 mmol). The reaction mixture was heated to 150 °C for 3 h and MeOH 
removed by distillation. The mixture was allowed to cool and then concentrated to 
give a white solid. After recrystallization from EtOAc-hexanes, white crystals were 
obtained (2.56g, 72.2%). Mp 85-86 °C (EtOAc-hexanes); IR (ATR): 3264 (b),
1751 (s), 1697 (s) cm*'; 'H NMR (400 MHz, CDCI3) Ô 7.28 (5H, m), 5.33 (1H. br 
s), 4.45 (1H. t, J1H-1H = 8.0 Hz), 4.14 (1H, dd, Jih-ih = 4.8 Hz, 8.0 Hz). 4.07 (1H, 
m). 2.84 (2H, d, Jih-ih = 5.3 Hz); '^0  NMR (100 MHz, CDCI3) ô 169.9, 136.1.
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129.2, 128.4, 127.6, 69.8, 59.9, 41.7 .
92 (4S)-3-Acetyl-4-(phenylmethyl)-1,3’Oxazotidin-2-one; Compound 91 (1.77 g,
10.0 mmol) was added into a stirred suspension of 95% NaH (0.29 g, 12.0 mmol) 
in dry THF (10 mL) at 0 ®C. After 3 h, AcCI (0.7 mL, 10.0 mmol) was added via 
syringe and the reaction stirred overnight at rt. The mixture was quenched by the 
addition of aq. sat. NH4CI (5 mL) and extracted with Et20 (3x10 mL). The extracts 
were combined, dried, filtered, and concentrated. The crude solid obtained was 
crystallized from EtOAc-hexanes to give white crystals (2.00 g, 91.1%). Mp 87-89 
®C (EtOAc-hexanes); ’H NMR (400 MHz, CDCI3) Ô 7.27 (5H, m), 4.69 (1H, m), 
4.17 (2H, m), 3.28 (1H, dd, J , h-ih  = 2.7 Hz, 13.3 Hz). 2.77 (1H, q, J ih -ih  = 7.1 Hz). 
2.56 (3H. s); '^C NMR (100 MHz, CDCI3) Ô 172.4, 170.1, 154.9, 129.8, 129.1, 
127.4, 66.1, 55.0. 47.8, 23.7.
93 (4S)-4-(Phenylmethyl)-3-propanoyl-1,3-oxazolidin-2-one: Procedure 1: 
Compound 91 (0.89 g, 5.0 mmol) was added into a stirred solution of 95 % NaH 
(0.14 g, 6.0 mmol) in dry THF (10 mL) at 0 °C. After 3 h, propionyl chloride (0.4 
mL, 5.0 mmol) was added via syringe and the reaction mixture stirred overnight at 
rt. The reaction was quenched by the addition of aq. sat. NH4CI (5 mL) and 
extracted with EtgO (3x10 mL). The extracts were combined, dried, filtered, and 
concentrated. The residue obtained was purified by chromatography on silica gel, 
eluting with EtOAc-hexanes (1:1), to give a faint yellow oil (1.01 g, 86.3%). 
Procedure 2: A solution of NaHMDS (6.0 mmol) in THF (6.0 mL) was added 
slowly via syringe to a stirred solution of 92 (1.10 g, 5.0 mmol) in dry THF (20 mL) 
at 0 °C. The solution turned bright yellow, an indicator for complete anion
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formation. Freshly distilled CH3I was filtered through basic alumina and added via 
syringe Into the reaction mixture. After 15 min the solution was allowed to warm 
to rt and then stirred for 3 h. The reaction was quenched with aq. sat. NH4CI (10 
mL). The mixture was diluted with 1 M NagSgOa (10 mL) and extracted with EtgO 
(3x20 mL). The combined organic extracts were washed with HgO (30 mL), dried 
over anhyd. NaaSOA, filtered, and concentrated. The product was purified by 
chromatography on silica gel, eluting with EtOAc-hexanes (1:1), as a faint 
yellowish oil (269 mg, 23.1%). IR (ATR): 1778 (s), 1703 (s), 1212 (s), 703 (s) cm 
\  'H NMR (400 MHz, CDCI3) 5 7.28 (5H, m), 4.65 (1H, m), 4.15 (2H, m), 3.25 (IN, 
dd, J ih -ih  = 3.2 Hz, 13.6 Hz), 2.92 (2H, m), 2.75 (1H, q, J ih .ih  = 7.8 Hz), 1.17 (3H, 
t, J1H-1H = 7.1 Hz); NMR (100 MHz, CDCI3) 8 174.0, 153.7, 133.2, 129.3,
128.8, 127.2, 66.1, 55.0, 37.8, 29.0, 8.2.
107 Benzyl 2-Acetyl-5-bromo-3-oxopentanoate: Dry pyridine (3.22 mL, 40 mmol) 
was added via syringe into a stirred suspension of benzyl acetoacetate (3.46 mL, 
20 mmol) and anhyd. MgCl2 (1.90 g, 20 mmol) in dry CH2CI2 (20 mL) at 0 °C.
After 15 min 3-bromopropionyl chloride (2.02 mL, 20 mmol) was added via 
syringe. The mixture was allowed to warm to rt after 1 h. The reaction was 
quenched with c. HCI (5 mL) and the mixture extracted with EtaO (3x50 mL). The 
extract was dried, filtered, and concentrated to give a yellow oil that was 
fractionated by chromatography on silica gel eluting with 20% EtOAc/hexanes. 
Only benzyl acetoactetate and benzyl 2-methyl-4-oxo-5,6-dihydro-4H-pyran-3- 
carboxylate were isolated. ’H NMR (400 MHz, CDCI3) 8; 7.36 (5H, m), 5.24 (2H, 
s), 4.39 (2H, t, J1H-1H = 5.7 Hz). 2.27 (2H, t. Jm-iH = 5.2 Hz), 2.05 (3H, s); NMR
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(100 MHz, CDCI3) ô 187.5, 177.8, 165.0, 135.7, 128.3, 127.9, 112.4, 67.7, 66 .5 ,
35.6, 20.0.
108 3-Methoxypropanoic acid: Methyl 3-methoxypropionate (11.7 mL, 100 mmol) 
was added into a stirred solution of Li0H»2H20 (8.39 g, 200 mmol) in HgO (80 
mL), MeOH (160 mL), and THF (240 mL) and then stirred overnight. The pH was 
adjusted to 2.5 with 5 M HCI and the mixture extracted with CH2CI2 (3x100 mL). 
The extracts were combined, dried, filtered, and concentrated. The crude product 
was purified by distillation to yield a faint yellow liquid (7.49g, 72%). Bp 65-66 °C 
(0.4 torry, ^H NMR (400 MHz, CDCI3) 5 11.73 (1H, br s), 3.63 (2H, t, Jih-ih = 6.1 
Hz), 3.33 (3H, s), 2.58 (2H, t, Jih-ih = 6.1 Hz); NMR (100 MHz, CDCI3) 6 
177.2, 67.5, 58.6, 34.7.
109 3-Methoxypropanoyl chloride: Oxalyl chloride (1.4 g, 16.5 mmol) was added 
into a stirred solution of 108 (1.56 g, 15.0 mmol) in dry Et20 (30 mL) at 0 °C. A 
catalytic amount of DMF (100 p-L) was added. The solution was stirred overnight 
at rt. The reaction mixture was concentrated. The liquid obtained was fractionally 
distilled to give the product as a clear liquid (1.70 g, 92.9%). ^H NMR (400 MHz, 
CDCI3) Ô 3.67 (2H, t, J1H-1H = 6.1 Hz), 3.35 (3H, s), 3.09 (2H, t, Jih-ih = 6.0 Hz); ^^0 
NMR (100 MHz, CDCI3) Ô 172.0, 67.1, 59.0, 46.9.
110 Phenylmethyl 2»acetyl-5-methoxy-3-oxopentanoate: Pyridine (11.0 mL, 137.0 
mmol) was added via syringe into a stirred suspension of anhyd. MgCb (6.5 g, 
68.5 mmol) and benzyl acetoacetate (11.8 mL, 68.5 mmol) in dry CH2CI2 (70 mL) 
at 0 “0. After 15 min, 109 (8.4g, 68.5 mmol) was added via cannula. The mixture
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was allowed to warm to rt and stirred overnight. The reaction mixture was 
acidified with 0.1 M HCI and extracted with EtgO (3x100 mL). The extracts were 
combined, dried, filtered, and concentrated. The crude product was purified by 
chromatography on silica gel, eluting with EtOAc-hexanes (1:3), to give a pale 
yellow liquid (17.13 g, 100%). IR (ATR); 1709 (s), 1072 (s). 752 (s); NMR (400 
MHz, CDCI3 ) Ô 17.85 (1H, s), 7.36 (5H, m), 5.24 (2H, s), 3.63 (2H. t. Jih-ih = 7.4 
Hz), 3.27 (3H, s), 2.93 (2H, t, Jih-ih = 4.4 Hz). 2.24 (3H, s); '=“0  NMR (100 MHz, 
CDCI3 ) 5 197.7, 196.2, 166.5, 135.6, 128.6, 128.5, 128.4, 128.2, 108.8, 68.4,
67.3, 59.0, 25.9.
111 6-Methoxyhexane-2,4-dione: Compound 110 (17.13 g, 68.5 mmol) and Pd on 
activated carbon (1.7 g, 10% Pd by weight) were suspended in dry THF (75.0 mL) 
and stirred vigorously under a Hz atmosphere (balloon) overnight. Celite was 
added to the reaction mixture, which was then filtered, and the residue washed 
with CHCI3 (3x100 mL). The filtrates were combined, concentrated, and purified 
by chromatography on silica gel, eluting with EtOAc-hexanes (1:3), to give a pale 
liquid (7.82 g, 79.2%). ’H NMR (400 MHz, CDCI3 ) 5 15.39 (1H, s), 5.50 (1H, s). 
3.60 (2H, m), 3.28 (3H, s). 2.47 (2H, m), 2.01 (3H. s); ^^C NMR (100 MHz, CDCI3 ) 
5 191.6, 100.2, 68.3, 58.5, 38.7, 24.6.
112 (3R,5R)-1-Methoxyhexa-3,5-dioI: Compound 111 (1.44 g, 10.0 mmol) and (+)- 
Ru(binap)(PPhz)2Cl2 (33.0 mg, 20.0 pmol) were dissolved in dry MeOH (2.0 mL) in 
a reactor which was placed in a Parr hydrogenation apparatus. The reaction was 
stirred at ca. 50 °C under 50 atm (740 psi) Hz pressure for 3 days. Celite was 
added to the resulting orange solution and removed by filtration. The dark-red
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filtrate was concentrated and purified by chromatography on silica gel, eluting with 
EtOH-hexanes (1:3), to give a clear oil (0.76 g, 51.8%). IR (ATR): 3390 (b), 1454 
(m), 1379 (m), 1169 (s). 1084 (s), 737 (s), 697 (s); ’ H NMR (400 MHz, CDCU) Ô
4.21 (2H. m). 3.60 (1H, m), 3.56 (1H, m). 3.39 (2H. s), 3.32 (3H, s), 1.83 (2H, m),
1.58 (2H. m). 1.19 (3H, d, Jih-ih = 7.2 Hz); NMR (100 MHz, CDCI3) Ô 71.8,
69.0, 64.7, 59.1, 44.3, 36.2, 23.6.
113 (3R,4R)-3,5-Bis-[(2,2-dimethyl)-propyl)-dlmethylsilanyloxy]-1> 
methoxyhexane: Compound 112 (2.93 g, 20.0 mmol), TBSCI (9.04 g, 60.0 
mmol), and imidazole (8.17 g, 120.0 mmol) were dissolved in dry DMF (20.0 mL) 
and stirred for 28 hrs. The reaction was quenched by the addition of H2O (80 mL) 
and extracted with CH2CI2 (3x60 mL). The organic extracts were dried, filtered, 
and concentrated. The crude oil obtained was fractionated by chromatography on 
silica gel, eluting with EtOH-hexanes (1:3), to give the product as an oil (5.53 g, 
100%). NMR (400 MHz, CDCI3) Ô 4.04 (1H, q, Jm-iH = 10.7 Hz), 3.81 (1H, m), 
3.39 (2H, m), 3.24 (3H, s), 1.66 (2H, m), 1.61 (2H, m), 1.05 (3H. d, Jih-ih = 5.3 
Hz), 0.82 (18H, s), 0.01 (12H, s); NMR (100 MHz, CDCI3) 6 69.4, 67.8, 66.3,
60.4, 58.5, 48.3, 37.9, 36.0, 34.2, 18.0, -0.42.
114 Phenylmethoxy 2-cyanoethane: A solution of NaOH (1.40 g, 35.0 mmol) in H2O 
(4.7 mL) was added dropwise to BnOH (51.7 mL, 0.5 mol) at 0 °C. Acrylonitrile 
(131.7 mL, 2.0 mol) was slowly added into the stirred mixture. After 30 min the 
reaction was allowed to warm to rt and stirred overnight. The reaction mixture 
was quenched with 1 M HCI (50 mL) and extracted with CH2CI2 (5*200 mL). The 
extracts were combined, dried, filtered, and concentrated to yield the product, a
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clear liquid (79.8 g, 99.0%). IR (ATR): 2251 (m), 1101 (s), 739 (s), 698 (s) cm'';
'H  NMR (400 MHz. CDCI3) Ô 7.35 (5H, m), 4.55 (2H. s), 3.62 (2H, t, J,h.ih = 6.4 
Hz), 2.56 (2H, t. J1H-1H = 6.1 Hz); NMR (100 MHz, CDCI3) 6 137.0, 128.2.
127.6, 127.4, 117.8, 72.8, 64.2, 18.5.
115 3-(Phenylmethoxy)-propanoic acid: Compound 114 (58.0 g, 360.0 mmol) was 
slowly added into a stirred solution of KOH (30.3 g, 540.0 mmol) in H2O (1080 
mL) and 30% H2O2 (140 mL). The suspension warmed up to 65 ”0. After the 
temperature stabilized, the reaction was heated at reflux overnight. An aliquot 
(250 pL) was tested with aq. sat. FeS04 (1 mL) for H2O2 content. The solution 
remained green, as a qualitative test that no peroxide was present. The reaction 
mixture was quenched with 5 M HCI (150 mL) and saturated with NaCl. The 
mixture was extracted with EtOAc (4^500 mL). The extracts were combined, 
dried, filtered, and concentrated. The residue obtained was purified by 
chromatography on silica gel, eluting with EtOAc-hexanes (1:4), to give a clear 
liquid (10.73 g, 29.8%). 'H NMR (400 MHz. CDCI3) Ô 7.36 (5H. m), 4.58 (2H. s), 
3.76 (2H, t, J1H-1H = 7.2 Hz, 2.69 (2H, Jih-ih = 6.9 Hz); '^C NMR (100 MHz, CDCI3) 
S 177.5, 137.5, 128.2, 127.6, 127.5, 72.9, 65.0, 34.7.
116 (2,2-Dimethyt)-propy) 2-acetyl-5-benzyloxy-3-oxopentanoate: Thionyl chloride 
(2.9 mL, 40 mmol) was added dropwise into neat 115 (3.60 g, 20.0 mmol) at 0 °C. 
The reaction mixture was allowed to warm to rt and then heated at reflux. The 
reaction mixture was concentrated after 2 h to give 3-(phenylmethoxy)-propanoyl 
chloride. Dry pyridine (2.4 mL, 30.0 mmol) was added via syringe into a stirred 
suspension of ferf-butyl acetoacetate (2.5 mL, 15.0 mmol) and anhyd. MgCb (1.43
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g, 15.0 mmol) in dry CH2CI2 (15.0 mL) at 0 °C. After 15 min, 3-(phenylmethoxy)- 
propanoyl chloride was added. The mixture was allowed to warm to rt and stirred 
overnight. The reaction mixture was acidified with 0.1 M HCI and extracted with 
EtzO (3x75 mL). The combined extracts were dried, filtered, and concentrated. 
The residue obtained was purified by chromatography on silica gel, eluting with 
EtOAc-hexanes (1:3), to give a reddish oil (3.44 g, 71.6%). NMR (400 MHz, 
CDCI3) 8 17.60 (1H, s), 7.32 (5H, m), 4.50 (2H, s), 3.74 (2H, t, Jih-ih = 6.6 Hz), 
2.97 (2H, t, J1H.1H = 6.5 Hz), 3.30 (3H, s), 1.53 (9H, s); NMR (100 MHz, CDCI3) 
S 195.7, 194.3, 166.0, 138.0, 128.2, 237.5, 127.4, 110.3. 81.4, 72.9, 65.8, 38.1,
28.0, 25.1.
117 Phenylmethyl 2-acetyl-5-benzyloxy-3-oxopentanoate: Thionyl chloride (14.5 
mL, 200.0 mmol) was added dropwise into neat 115 (18.0 g, 100.0 mmol) at 0 °C. 
The reaction mixture was allowed to warm to rt and then heated at reflux. The 
reaction mixture was concentrated after 2 h to give 3-(phenylmethoxy)-propanoyl 
chloride. Dry pyridine (14.5 mL, 180.0 mmol) was added via syringe into a stirred 
suspension of benzyl acetoacetate (15.6 mL, 90.0 mmol) and anhyd. MgCL (8.57 
g, 90.0 mmol) in dry CH2CI2 (90 mL) at 0 °C. After 15 min, 3-(phenylmethoxy)- 
propanoyl chloride (19.87 g, 100.0 mmol) was added directly. The mixture was 
allowed to warm to rt after 1 h. The reaction was acidified with 0.1 M HCI and 
extracted with Et20 (3*150 mL). The extracts were combined, dried, filtered, and 
concentrated. The product was obtained by chromatography on silica gel, eluting 
with EtOAc-hexanes (1:4), to give a faint yellow oil (21.59 g, 67.7%). ^H NMR 
(400 MHz, CDCI3) 8 17.97 (1H, s), 7.21 (10H, m), 5.21 (2H, s), 4.44 (2H. s), 3.73 
(2H, t, = 6.7 Hz), 3.02 (2H, t, J,h-ih  = 4.6 Hz). 2.11 (3H, s); '"C NMR (100
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MHz, CDCl3)8 195.6, 166.5, 137.9, 135.3, 128.4, 128.3, 128.1, 127.4, 108.6,
72.7, 6 6 .6 , 65.6, 38.3, 25.5.
118 1-Phenyimethoxyhexa-3,5-dione: Procedure 1: TFA (12.0 mL, 156.0 mmol) was 
added by syringe to a solution of 116 (3.20 g, 10.0 mmol) in CH2CI2 (36.0 mL). 
The color changed to red and within 15 min reverted back to a faint yellow, 
indicating completion of the reaction. The reaction mixture was diluted with 
CH2CI2 (50 mL) and washed with aq. sat. NaHCOa (4x50 mL). The organic phase 
was dried, filtered, and concentrated. The product obtained was purified by 
chromatography on silica gel eluting with EtOAc-hexanes (1:3), as a clear liquid 
(290 mg, 13.2%).
Procedure 2: Compound 117 (3.54 g, 10.0 mmol) and palladium doped with 
ethylene diamine on activated carbon (0.35 g, 10% Pd(en) by weight) were 
suspended in dry THF (10.0 mL) and stirred vigorously under a H2 atmosphere 
(balloon) for 24 h. Celite was added to the reaction mixture, which was then 
filtered, and the residue washed with CHCI3 (80 mL). The combined organic 
fractions were concentrated, and the product obtained by chromatography on 
silica gel, eluting with EtOAc-hexanes (1:3), as a pale yellowish liquid (2.11 g, 
95.7%). 'H NMR (400 MHz, CDCI3) 6 7.29 (5H, m), 5.41 (2H, s), 4.52 (2H, s), 
3.69 (2H, t, = 6.5 Hz), 3.49 (2H. t, Jih-ih = 5.8 Hz), 1.99 (3H, s); '®C NMR 
(100 MHz, CDCWô 192.7, 139.1, 129.5, 128.8, 128.7, 101.6, 74.1, 67.0, 39.9.
119 (2,2-Dimethyl)-propyl 2-acetyl-3-oxohex-5-enoate: Oxalyl chloride (10.0 mL,
120.0 mL) was added via syringe to stirred neat vinylacetic acid (9.3 mL, 110.0 
mmol) at 0 °C, followed by the addition of 2 drops of DMF. The solution was
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stirred for 2.5 h to generate 3-butenoyl chloride. Dry pyridine (16.1 mL, 200.0 
mmol) was added via syringe into a stirred suspension of fert-butyl acetoacetate 
(16.6 mL, 100.0 mmol) and anhyd. MgCb (9.52 g. 100.0 mmol) in dry CH2CI2 (100 
mL) at 0 °C. After 15 min the crude 3-butenoyl chloride was added directly. The 
mixture was allowed to warm to rt and stirred overnight. The reaction mixture was 
acidified and extracted with EtaO (3x50 mL). The extracts were combined, dried, 
filtered, and concentrated. The crude product obtained was purified by 
chromatography on silica gel, eluting with EtOAc-hexanes (1:3), to give a clear oil 
(11.0 g, 48.7%). 'H NMR(400MHz, CDCl3)6 17.41 (1H,s), 5.91 (1H, m). 5.15 
(2H, m). 3.42 (2H, d, Jih-ih = 3.9 Hz). 1.52 (9H, s). 1.44 (3H, s); NMR (100 
MHz, CDCl3)S 196.0, 166.4, 133.0, 118.7, 51.3, 42.1, 31.8, 28.0, 14.1.
122 4-Phenyl•3>butenoic acid: A stirred suspension of malonic acid (4.94 g, 47.5
mmol) in phenylacetaldehyde (5.8 mL, 50.0 mmol) and dry pyridine (4.0 mL, 50.0 
mmol) was heated at reflux for 24 hrs. The reaction mixture was allowed to cool 
and then quenched with H2O (100 mL). The aqueous phase was acidified with 1 
M HCI and extracted with EtOAc (2x100 mL). The organic extracts were 
combined and washed with 1M NaOH (100 mL). The aqueous phase was 
acidified with c. H2SO4 and extracted with EtOAc (100 mL). The combined 
extracts were dried, filtered, and concentrated. The crude solid obtained was 
recrystallized to give fine white crystals (5.05 g, 65.6%). Mp 69-71 °C (Et20- 
hexanes); IR (ATR): 1698 (s). 1221 (m), 1209 (m). 743 (s), 692 (s); 'H NMR (400 
MHz, GDCI3) 5  7.37 (5H, m), 6.50 (1H, d, J ih -ih  = 15.7 Hz), 6.30 (1H, m), 3.31 
(2H, d, J1H-1H = 6.8 Hz); NMR (100 MHz, CDCI3) ô 178.4, 136.6, 134.0, 128.5,
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127.7, 126.3, 120.7, 38.0.
123 (2,2-Dimethyl)-propyl 2-acetyl-3-oxo-6-phenylhex-5-enoate: Oxalyl chloride 
(2.6 mL, 30.0 mmol) was added via syringe to a stirred solution of 122 (2.43 g,
15.0 mmol) in dry EtzO (4.0 mL), followed by addition of 2 drops of DMF. The 
reaction mixture was stirred at room temperature for 4 h. The excess oxalyl 
chloride was evaporated and the crude solid recrystallized to yield 4-phenyl-3- 
butenoyl chloride as orange crystals (1.10 g, 40.6%). Mp 40-42 °C (petroleum 
ether). Dry pyridine (3.2 mL, 40.0 mmol) was added via syringe to a stirred 
solution of ferf-butyl acetoacetate (3.3 mL, 20.0 mmol) and anhyd. MgClg (1.90 g,
20.0 mmol) in dry CH2CI2 (20 mL) at 0 °C. 4-Phenyl-3-butenoyl chloride was 
added, the mixture was allowed to warm to rt and stirred overnight. The reaction 
mixture was acidified with 0.1 M HCI and extracted with Et20 (3x100 mL). The 
extracts were combined, dried, filtered, and concentrated. The crude product was 
purified by chromatography on silica gel, eluting with EtOAc-hexanes (1:9). as a 
colorless oil (5.39 g, 89.1%). IR (ATR); 2977 (b), 1703 (s), 1082 (s), 754 (m), 691 
(s); 'H  NMR (400 MHz, CDCI3) 8  17.58 (1H, s), 7.25 (5H, m), 6.40 (1H, d, J , h - i h  =
16.0 Hz). 6.34 (1H, m ) , 3.60 (2H, d, Jih-ih = 5.7 Hz), 2.31 (3H, s), 0.54 (9H, s); 
NMR (100 MHz, CDCI3) 8 196.0, 194.4 (enol resonance). 166.1, 136.8, 133.5,
128.4, 127.3, 126.1. 122.4, 109.9, 81.6, 41.5, 28.1, 25.1.
124 7-Phenylhept-6-ene-2,4-dione: Neat TFA (12 mL, 156 mmol) was added into a 
stirred solution of 123 (3.21 g, 10.6 mmol) in CH2CI2 (36 mL). The color changed 
to Bordeaux-red. Within 5 min, it reverted back to light yellow, indicating complete 
reaction. The reaction mixture was diluted with CH2CI2 (50 mL) and washed with
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aq. sat. NaHCOa (3x75 mL). The organic phade was anea, filtered, and 
concentrated. The yellow oil obtained was purified by Kugelrohr distillation to 
yield 124 as a faint yellow oil (1.89 g, 88.0 %). NMR (400 MHz, C D C I3 ) ô 
15.43 (1H, br s), 7.31 (5H. m). 6.47 (1H, d, Jih-ih = 15.4 Hz), 6.28 (1H, m), 5.55 
(1H, s), 3.20 (2H, d, J ih -ih  = 5.1 Hz), 2.04 (3H, s); NMR (100 MHz, C D C I3 ) Ô
192.8, 190.9 (enol resonance), 136.8, 133.8, 128.6, 127.6, 126.3, 122.5, 121.3,
99.5, 42.5, 24.6.
125 Phenylmethyl 2-acetyi-3-oxobutanoate: Dry pyridine (16.2 mL, 200.0 mmol) 
was added via syringe to a stirred solution of benzyl acetoacetate (17.3 mL, 100.0 
mmol) and anhyd. MgClz (9.52 g, 100.0 mmol) in dry CH2CI2 (90 mL) at 0 °C.
After 15 min phenylacetyl chloride (14.5 g, 110.0 mmol) in dry CH2CI2 (10 mL) 
was added. The mixture was allowed to warm to rt and then stirred overnight.
The reaction mixture was acidified with 0.1 M HCI and extracted with Et20 (3x100 
mL). The combined extracts were dried, filtered, and concentrated. The crude 
product was purified by chromatography on silica gel, eluting with EtOAc-hexanes 
(1:3), as a colorless oil (23.0 g, 74.0%). ^H NMR (400 MHz, CDCI3) Ô 17.80 (1H, 
s), 7.35 (10H, m), 5.25 (2H, s). 4.03 (2H, s), 2.28 (3H, s); '^0 NMR (100 MHz, 
CDCI3) Ô 196.7, 196.1 (enol resonance), 167.0, 135.4, 134.9, 129.5, 129.4, 129.0,
128.8, 128.7, 128.6,128.5, 128.4, 108.5, 67.0, 43.9, 25.8.
126 1-Phenyl-2,4-pentadlone: Compound 125 (69.7 g, 225.0 mmol) and Pd on 
activated carbon (3.48 g, 5% Pd by weight) were suspended in dry THF (200.0 
mL) and stirred vigorously under a H2 atmosphere (balloon) overnight. Celite was 
added to the reaction mixture, which was then filtered, and the residue washed
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with CHCU (4x1 OOmL). The combined filtrates were concentrated to give an 
orange liquid that was purified by Kugelrohr distillation (29.5 g, 74.4%). IR (ATR); 
1712 (s), 1599 (s), 1236 (s). 697 (s) cm \  NMR (400 MHz, CDCI3) 5 7.30 (5H, 
m), 5.42 (1H, s). 3.63 (1H, s), 3.55 (2H, s), 1.96 (3H, s); NMR (100 MHz, 
CDCI3) 8 191.5, 129.7, 129.4, 128.8, 128.6, 127.1, 99.9, 45.1, 41.0, 24.8.
127 {2R, 4R)-1-Phenyl-2,4-pentadiol: Compound 126 (8.81 g, 50.0 mmol) and (+)- 
Ru(binap)(PPh2)2Cl2 (80.0 mg, 100.0 nmol) were dissolved in dry MeOH (7.5 mL) 
in a reactor which was placed in a Parr hydrogenation apparatus. The reaction 
was stirred at 50 °C under 52 atm (760 psi) Hz pressure for 3 days. Celite was 
added to the solution, removed by filtration, and washed with MeOH (100 mL). 
The filtrates were concentrated, and purified by Kugelrohr distillation under 
vacuum to yield a faint yellow liquid (8.31 g, 92.2%). Bp 100 °C (0.08 forr); IR 
(ATR): 3358 (b). 1454 (s), 1436 (s), 699 (s) cm '; 'H NMR (400 MHz, CDCI3) 8 
7.23 (5H, m). 4.13 (2H, br s), 2.73 (2H, m), 2.24 (2H, brs). 1.61 (2H, m), 1.20 
(3H, d, J ih -ih  = 2.7 Hz); '^C NMR (100 MHz, CDCI3) 8 138.2, 129.4, 128.6, 126.5, 
70.1,65.3, 44.0. 43.5, 23.5.
128 (4R, 6R)-4-Phenylmethy[-2,2,6-trlmethyl-1,3-dioxane: Dry 2,2- 
dimethoxypropane (2.5 mL, 20.0 mmol) was added to a stirred solution of 127 
(1 80g, 10.0 mmol) in dry benzene (10.0 mL). Recrystallized p-TsOH (100 mg,
0.5 mmol) was added and the mixture heated at reflux for 8 h. The reaction 
mixture was diluted with HgO (10 mL) and extracted with EtzO (3x20 mL). The 
extracts were combined, dried, filtered, and concentrated. The residue obtained 
was purified by chromatography on silica gel, eluting with EtsN-EtOAc-hexanes
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(2.5%:1%;96.5%). to give a clear liquid (1.02 g. 45.7%). NMR (400 MHz,
CeDe) Ô 7.28 (5H, m), 4.10 (1H, m), 3.98 (1H, m), 2.79 (2H, dq, J ih-ih = 6.2 Hz,
= 93.3 Hz). 1.70 (H, m), 1.37 (3H, s). 1.33 (3H, s), 1.15 (3H, d, Jih-ih = 6.7 
Hz); NMR (100 MHz, CDCI3) 6 129.2, 128.4. 128.2, 127.4, 126.2, 100.2, 67.4.
62.8, 42.1, 39.5. 25.0, 24.9, 21.7.
129 {2R, 4R)-1-Phenyl-2,4-pentadiol acetate: Distilled AC2O (2.8 mL, 30.0 mmol)
was added to a solution of 127 (1.80 g, 10.0 mmol), pyridine (2.4 mL, 30.0 mmol), 
and DMAP (98 mg, 0.8 mmol) in dry CH2CI2 (40 mL) at 0 °C. The mixture was 
allowed to warm to rt after 1 h, and then stirred for 1 h. The reaction mixture was 
diluted with H2O (40 mL) and extracted with CH2CI2 (3x20 mL). The extracts were 
combined, washed with aq. sat. NaCI, dried, filtered, and concentrated. The 
residue obtained was purified by chromatography on silica gel, eluting with 
EtOAc-hexanes (1:3), to give a clear liquid that solidified upon standing (1.75 g, 
66.1%). 'H NMR (400 MHz, CDCI3) Ô 7.19 (5H, m), 5.16 (1H, m), 4.95 (1H, m), 
2.85 (2H, dq, Jih-ih = 6.7 Hz. = 28.1 Hz), 2.00 (6H. d. Jih-ih = 5.5 Hz), 1.72 
(2H. m). 1.19 (3H, d, Jih-ih = 6.1 Hz); '"C NMR (100 MHz, CDCI3) Ô 170.6, 170.3,
136.9, 129.5, 128.4, 126.6, 70.6, 66.8, 40.9, 39.6, 21.2, 21.0, 20.4.
130 {ZR, 5R)-3,5-Diacetyloxyhexanoic acid: Ozone was bubbled through a solution 
of 129 (3.96 g, 15.0 mmol) in dry CH2CI2 (150 mL) at rt for 8 h. The characteristic 
blue color of excess ozone was observed. The solution was purged with oxygen 
for 5 min. The reaction mixture was diluted with H2O (150 mL), quenched with 
30% H2O2 (90 mL), and left stirring at rt for 12 h. The mixture was extracted with 
CH2CI2 (3x150 mL). The extracts were combined, dried, filtered, and
80
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
concentrated. The residue obtained was purified by chromatography on silica gel, 
eluting with a gradient of EtOAc/hexanes (1:3 to 1:1), to give 130 as a clear oil 
(808 mg, 23.2%). IR (ATR): 2984 (b), 1736 (s). 1242 (s). 1177 (m), 907 (s), 728 
(s) cm '; 'H  NMR (400 MHz, CDCU) 5 10.86 (IN , b), 5.24 (1H, m), 4.94 (1H, m),
2.59 (2H, m), 2.07 (3H, s), 2.01 (3H, s), 1.84 (2H, m), 1.21 (3H, d. J ih-ih = 6.1 Hz);
NMR (100 MHz, CDCI3) 6 175.2, 170.8, 170.3, 66.7, 66.4, 39.9, 38.9, 21.0, 
20.8, 20.2 .
131 (2R, 5R)*3,5-Diacetyloxyhexanoi: A solution of BHs'THF (14.4 mmol) in THF 
(14.4 mL) was added via syringe into a stirred solution of 130 (2.79 g, 12.0 mmol) 
in dry THF (48 mL) at 0 °C. The reaction mixture was allowed to warm to rt and 
then stirred for 5 h. The reaction was quenched with aq. sat. NH4CI (20 mL). The 
mixture was extracted with CH2CI2 (3x75 mL). The combined extracts were 
washed with aq. sat. NaCI (75 mL), dried, filtered, and concentrated. The residue 
obtained was purified by chromatography on silica gel, eluting with EtOAc- 
hexanes (1:1), to give a faint yellow oil (353 mg, 13.5%). 'H NMR (400 MHz, 
CDCI3) 5 4.99 (1H, m), 4.76 (1H, m). 3.47 (2H, m), 2.98 (1H, b), 1.86 (6H, d, Jm-in 
= 14.9 Hz), 1.68 (2H, m), 1.59 (2H, m), 1.13 (3H. d, Jm-m = 199 Hz); NMR 
(100 MHz, CDCI3) 5 171.6, 170.5, 67.4, 66.5, 57.9, 40.6, 37.4, 20.9, 20.7, 20.2.
132 Phenylmethyl 2-acetyl-4-(3,4-dlmethoxyphenyl)-3-oxobutanoate: Dry pyridine 
(3.2 mL, 40.0 mmol) was added via syringe to a stirred solution of benzyl 
acetoacetate (3.5 mL, 20.0 mmol) and anhyd. MgCIa (1.90 g, 20.0 mmol) in dry 
CH2CI2 (15 mL) at 0 “0. After 15 min 3,4-dimethoxyphenylacetyl chloride (4.94 g,
23.0 mmol) in dry CH2CI2 (5 mL) was added. The mixture was allowed to warm to
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rt and then stirred overnight. The reaction mixture was acidified with 0.1 M HCI 
and extracted with EtgO (3x50 mL). The extracts were combined, dried, filtered, 
and concentrated. The crude product was purified by chromatography on silica 
gel, eluting with EtOAc-hexanes (1:3), to give a colorless oil (5.65 g, 76.3%). IR 
(ATR): 1710 (s). 1514 (s), 1262 (s), 1238 (s), 1070 (s), 1030 (s) cm '; 'H NMR 
(400 MHz, CDCI3) 6 7.36 (5H. m), 6.74 (3H, m), 5.42 (2H. s). 3.94 (2H, s), 3.83 
(3H, s). 3.79 (3H, s). 2.30 (3H, s); '^0 NMR (100 MHz. CDCI3) S 196.5, 195.6 
(enol resonance), 166.7, 148.6, 147.9, 135.1, 128.5, 128.4, 128.3, 121.4, 112.4,
110.9, 66.7, 55.6, 55.5, 43.1, 25.4.
133 1-(3,4-Dimethoxyphenyl)-penta>2,4-dione: Compound 132 (5.37 g, 14.5 mmol) 
and Pd on activated carbon (0.5 g, 10% Pd by weight) were suspended in dry 
THF (15.0 mL) and stirred vigorously under a Hz atmosphere (balloon) overnight. 
Celite was added to the reaction mixture, which was then filtered, and the residue 
washed with CHCI3 (3x100 mL). The combined organic phases were 
concentrated to give an orange liquid that was purified by chromatography on 
silica gel, eluting with EtOAc-hexanes (1:1), to give a pale yellowish oil (3.12 g, 
91.1%). 'H NMR (400 MHz, CDCI3) 6  15.39 (0.9 H, br s. enol), 6.79 (1H, d, J ih -ih  
= 7.9 Hz), 6.76 (1H, d. Jih-ih = 1 8  Hz), 6.73 (1H, s). 5.41 (0.9H, s, enol), 3.85 
(3H, s), 3.84 (3H. s), 3.49 (2H, s), 1.99 (3H, s); '^C NMR (100 MHz, CDCI3) 6
192.7, 190.9 (keto), 148.9 (keto), 148.0 (enol), 127.4, 121.7, 121.4, 112.3, 111.3,
111.2, 99.6 (enol), 55.7, 44.6, 24.6.
134 (2/?, 4R)-1-(3,4-Dimethoxyphenyl)-penta-2,4-diol: Compound 133 (7.33 g, 31.0 
mmol) and (+)-Ru(binap)(PPh2)2Cl2 (50.0 mg, 62.0 ^mol) were dissolved in dry
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MeOH (6.0 mL) in a reactor which was placed in a Parr hydrogenation apparatus. 
The reaction was stirred at 45 °C under 82 atm (1200 psi) Hz pressure for 5 days. 
Celite was added to the solution, which was then filtered. The filtrate was 
concentrated and purified by Kugelrohr distillation under vacuum (0.15 torr) to 
yield a very viscous oil (4.89 g, 48.6%). ^H NMR (400 MHz. CDCU) 5 6.77 (3H. 
m). 4.12 (2H, m), 3.87 (6H, s). 2.56 (1H, t, Jih-ih = 6.5 Hz), 2.43 (1H. t. J,h-ih = 6.5 
Hz), 2.04 (3H. s). 1.88 (2H. m). 1.25 (3H, s).
135 (2R,4R)-1-(3,4-Dimethoxyphenyl)-penta>2,4-diol acetate; Distilled AczO (14.1 
mL, 150.0 mmol) was added to a solution of 134 (4.86 g, 15.0 mmol) in dry 
pyridine (24.2 mL, 300.0 mmol) at 0 °C. The mixture was allowed to warm to rt 
after 1 h and then stirred overnight. The reaction mixture was diluted with CHzCU 
(100 mL) and washed twice with aq. CUSO4 (100 mL), followed by a wash with 
HzO (100 mL) and then aq. sat. NaHCOa (100 mL). The organic phase was dried, 
filtered, and concentrated. The residue obtained was purified by chromatography 
on silica gel, eluting with EtOAc-hexanes (1:3), to give a clear liquid (1.03 g, 
21.3%). 'H NMR (400 MHz, CDCU) 8 6.74 (3H, m). 6.68 (5H, m), 5.01 (1H, m). 
4.92 (1H, m), 3.84 (7H, d, Jih-ih = 1-2 Hz), 3.83 (7H, d. Jm-iH = 2.4 Hz), 2.53 (2H, 
t, = 7.6 Hz), 2.40 (2H. t. Jih*ih = 7.3 Hz), 2.09 (2H, s), 2.05 (2H. s), 1.97 (6H, 
s); ’^C NMR (100 MHz, CDCU) 5 170.6, 170.3, 148.6,147.3, 121.4, 120.1, 112.5,
70.6, 66.8, 55.8, 55.7, 40.3, 39.5, 34.5, 25.2, 21.1, 20.3.
144 Methyl 3-bromopropanoate: A solution of 3-bromopropionic acid (38.25 g. 250.0 
mmol) in CH3OH (100 mL) was cooled to 0 °C and c. H2SO4 (1.3 mL, 25.0 mmol) 
was added. The solution was heated at reflux for 12 h. The reaction mixture was
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cooled, diluted with CH2CI2 (200 mL), and washed witn aq. sat. NaHCOa (2*150 
mL). The organic extracts were combined, dried, filtered, and concentrated to 
yield a colorless liquid (35.6 g, 85.2%). IR (ATR): 1735 (s), 1237 (m), 1214 (s), 
616 (m) cm-\ NMR (400 MHz, CDCI3) Ô 3.68 (3H. s), 3.53 (2H, t, Jih-ih = 9.9 
Hz, 2.49 (2H, t, v/ih-ih = 9.3 Hz); NMR (100 MHz, CDCI3) Ô 170.8, 51.8, 37.3,
25.7.
145 Methyl 3-cyanopropanoate; A solution of 144 (5.83 g, 35.0 mmol) in EtOH (35 
mL) was added to a solution of KCN (2.27 g, 35.0 mmol) in H2O (35.0 mL) and 
then stirred for 2 days at rt. Carefully, 4 M HCI was added to adjust the pH to 6. 
The reaction mixture was extracted with Et20 (3*75 mL). The combined organic 
extracts were washed with H2O (2*100 mL), dried, filtered, and concentrated.
The residue was purified by chromatography on silica gel, eluting with an EtOAc- 
hexanes (1:3 to 1:1) gradient, to give an oil (1.13 g, 28.4%). IR (ATR): 2253 (w), 
1736 (s), 1244 (m), 1206 (m), 1177 (m), 1046 (w), 752 (s) cm '; 'H NMR (400 
MHz, CDCI3) Ô 3.70 (3H, s), 2.63 (4H, m); '^C NMR (100 MHz, CDCI3) 8 170.4,
118.4, 52.1,29.4, 12.7.
143 3-Cyanopropanolc acid: A solution of UGH (361 mg, 8.6 mmol) in H2O (3.5 mL) 
was added to a solution of 145 (487 mg, 4.3 mmol) in THF (3.5 mL). The mixture 
was stirred for 6 h at rt. The reaction mixture was concentrated to ca. 2 mL and 
dissolved in H2O (3 mL). The solution was extracted with Et20 (3*50 mL). The 
combined extracts were dried, filtered, and concentrated. The resulting viscous 
liquid crystallized upon cooling on ice. After recrystallization from CHCI3, the 
product was collected as white crystals (185 mg, 43.5%). 'H NMR (400 MHz,
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DzO) S 2.60 (4H. m); '"C NMR (100 MHz, CDCI3) 5 175.9, 95.5, 30.3, 13.4.
146 Benzyl 3-hydroxybutanoate; Powdered NaBH4 (0.11 g, 3.0 mmol) was added to 
a solution of benzyl acetoacetate (1.7 mL, 10.0 mmol) In H2O (15.0 mL) in dry 
THF (85.0 mL) at 0 °C. The reaction was stirred for 40 min before dilution with 
H2O (70 mL) and extraction with Et20 (3x50 mL). The extracts were combined, 
dried, filtered, and concentrated to give a yellow oil, which was purified by 
chromatography on silica gel, eluting with EtOAc-hexanes (1:3), to give a 
colorless oil (1.94 g, 99.9%).
(3R)-Benzyl 3>hydroxybutanoate: Benzyl acetoacetate (8.6 mL, 50.0 mmol) and 
(+)-Ru(binap)(PPh2)2Cl2 (25 mg, 20 pmol) were dissolved in dry MeOH (10.0 mL) 
in a reactor which was placed in a Parr hydrogenation apparatus. The reaction 
was stirred at ca. 30 °C under 82 atm (1200 psi) H2 pressure for 36 h. Celite was 
added to the reaction mixture, which was then filtered. The filtrate was 
concentrated and purified by Kugelrohr distillation to give 146 (9.71 g, 99.96%).
'H NMR (400 MHz, CDCI3) Ô 7.26 (5H, m), 5.03 (2H, s), 4.13 (IN, m), 2.42 (2H, d, 
= 9.8 Hz), 1.12 (3H. d, Jih-ih = 7.9 Hz); NMR (100 MHz, CDCI3) 5 172.2,
135.4, 128.1, 128.0, 126.6, 66.1, 64.0, 42.8, 22.3.
147 3-Hydroxybuturic acid; Compound 146 (11.37 g, 58.5 mmol) and Pd on
activated carbon (1.14 g, 10% Pd by weight) were suspended in dry THF (100.0 
mL) and stirred vigorously overnight under a H2 atmosphere (balloon). Celite was 
added to the reaction mixture, which was then filtered, and the residue washed 
with CHCI3 (3x75 mL). The combined organic fractions were concentrated, and 
the product purified by vacuum distillation to give a clear liquid (5.93 g, 97.4%).
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Bp 63 °C (0.15 torr); IR (ATR): 2975 (b), 1709 (s) cm '\ ’ H NMR (400 MHz, CDCI3) 
Ô 7.54 (2H. brs). 4.19 (1H, m). 2.42 (2H, m), 1.16 (3H, d, Jih-ih = 6.7 Hz);
NMR (100 MHz. CDCI3) S 176.5, 64.3, 42.4, 22.2.
148 2 (1,1 -Dimethylethyl)-6-methyl-1,3-dioxan-4-one: Compound 147 (1.85 mL,
20.0 mmol), Sc(OJf)3 (0.39 g, 0.8 mmol), and pivalaldehyde (3.26 mL, 30.0 mmol) 
were dissolved In dry CH2CI2 (200 mL) and heated at reflux. The condensed 
vapors were dripped through a Soxhlett extractor with 4Â molecular sieves. After 
6 h the reaction mixture was allowed to cool and washed with H2O (3^75 mL).
The organic layer was dried, filtered, and concentrated. The residue obtained 
was purified by chromatography on silica gel, eluting with EtOAc-hexanes (1:9), to 
give 148 as a clear oil (0.9 g, 26.1%). ^H NMR (400 MHz, CDCU) Ô 4.85 (1H, s), 
3.96 (1H, m), 2.58 (1H. dd, J^h-w = 4.8 Hz, Jih-ih = 16.0 Hz). 2.34 (1H. dd, =
8.0 Hz. Jih-ih = 16.0 Hz), 1.25 (3H, d, Jih-ih = 7.8 Hz), 0.90 (9H, s); '^C NMR (100 
MHz, CDCU) 5 168.3, 108.5, 70.4, 37.4, 35.1,23.9, 21.1.
149 2-(1,1-Dimethylethyl)-6-methyl-1,3-dloxan-4-yl acetate: Compound 148 (1.41 
g, 8.2 mmol) was dissolved in dry CH2CU (32 mL) and cooled to -78 °C. DIBALH 
(9.0 mmol) in CHgCU (9 mL) was slowly added via syringe, with the temperature 
remaining below —70 "̂ C. After 3 h, pyridine (2.0 mL, 24.6 mmol) was added, 
followed by DMAP (1.10 g, 9.0 mmol) dissolved in dry CH2CU (16 mL), and then 
distilled AcaO (3.1 mL, 32.8 mmol). The mixure was allowed to warm to rt and 
stirred for 2 h. The reaction was quenched with aq. sat. NH4CI (25 mL) and then 
stirred for 30 min. The mixture was extracted with CH2CU {3x20 mL), and the 
organic phase washed twice with 1 M aq. Oxone® (20 mL), twice with aq. sat.
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NaHCOs (20 mL), and once with aq. sat. NaCI (20 mL). The organic fraction was 
dried, filtered, and concentrated. The product was obtained by chromatography 
on silica gel, eluting with EtaN-EtOAc-hexanes (1:10:89), as a clear liquid (0.3 g, 
16.9%). NMR (400 MHz, CDCI3) 5  5.81 (1H, dd, J ih -ih  = 1.3 Hz, J ih -ih  = 10.7 
Hz). 4.22 (1H, s), 3.75 (1H, m). 2.10 (3H, s), 1.73 (2H, m). 1.26 (3H, s), 0.92 (9H, 
s); ’^0 NMR (100 MHz, CDCU) 5 169.2, 105.1, 93.4, 70.9, 37.4, 34.6, 24.6, 24.3,
21 .2 .
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